Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-127-3p PPARG -0.63 0.04008 0.8 0.14249 miRanda -0.27 0.00145 NA
2 hsa-miR-130a-3p PPARG 2.02 0 0.8 0.14249 miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP -0.21 0.01438 NA
3 hsa-miR-142-3p PPARG 2.75 0 0.8 0.14249 miRanda -0.29 1.0E-5 NA
4 hsa-miR-27a-3p PPARG 1.67 0 0.8 0.14249 MirTarget; miRNATAP -0.61 0 NA
5 hsa-miR-338-5p PPARG -0.58 0.04722 0.8 0.14249 MirTarget; PITA; miRNATAP -0.42 0 NA
6 hsa-miR-34c-5p PPARG 2.07 0 0.8 0.14249 miRanda -0.32 1.0E-5 NA
7 hsa-miR-455-5p PPARG 2.26 0 0.8 0.14249 miRanda -0.29 0.00047 NA
8 hsa-miR-511-5p PPARG 1.04 0.00234 0.8 0.14249 MirTarget -0.34 1.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 REGULATION OF CELL PROLIFERATION 175 1496 9.237e-70 4.298e-66
2 POSITIVE REGULATION OF RESPONSE TO STIMULUS 190 1929 4.737e-64 1.102e-60
3 REGULATION OF CELL DEATH 164 1472 1.001e-61 1.553e-58
4 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 180 1848 2.146e-59 2.496e-56
5 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 155 1395 8.665e-58 8.063e-55
6 IMMUNE SYSTEM PROCESS 184 1984 1.408e-57 1.092e-54
7 RESPONSE TO OXYGEN CONTAINING COMPOUND 150 1381 1.997e-54 1.327e-51
8 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 170 1805 1.646e-53 9.572e-51
9 POSITIVE REGULATION OF GENE EXPRESSION 166 1733 4.148e-53 2.145e-50
10 NEGATIVE REGULATION OF CELL DEATH 117 872 3.79e-51 1.763e-48
11 RESPONSE TO ENDOGENOUS STIMULUS 149 1450 6.529e-51 2.762e-48
12 REGULATION OF CELL DIFFERENTIATION 150 1492 4.552e-50 1.765e-47
13 LOCOMOTION 128 1114 1.63e-48 5.833e-46
14 RESPONSE TO EXTERNAL STIMULUS 163 1821 5.298e-48 1.643e-45
15 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 156 1672 5.127e-48 1.643e-45
16 RESPONSE TO LIPID 113 888 6.078e-47 1.767e-44
17 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 125 1142 5.417e-45 1.483e-42
18 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 104 799 5.898e-44 1.525e-41
19 POSITIVE REGULATION OF CELL COMMUNICATION 143 1532 1.296e-43 3.175e-41
20 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 130 1275 1.744e-43 4.058e-41
21 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 154 1784 4.859e-43 1.077e-40
22 REGULATION OF RESPONSE TO STRESS 138 1468 2.698e-42 5.707e-40
23 REGULATION OF IMMUNE SYSTEM PROCESS 134 1403 9.951e-42 2.013e-39
24 POSITIVE REGULATION OF CELL PROLIFERATION 102 814 1.459e-41 2.829e-39
25 RESPONSE TO ORGANIC CYCLIC COMPOUND 108 917 1.566e-41 2.915e-39
26 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 138 1492 1.724e-41 2.97e-39
27 REGULATION OF PHOSPHORUS METABOLIC PROCESS 144 1618 1.713e-41 2.97e-39
28 CELL MOTILITY 103 835 2.334e-41 3.744e-39
29 LOCALIZATION OF CELL 103 835 2.334e-41 3.744e-39
30 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 105 876 4.935e-41 7.654e-39
31 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 145 1656 5.651e-41 8.482e-39
32 REGULATION OF PROTEIN MODIFICATION PROCESS 146 1710 5.419e-40 7.879e-38
33 REGULATION OF CELLULAR COMPONENT MOVEMENT 97 771 1.322e-39 1.863e-37
34 TISSUE DEVELOPMENT 136 1518 2.74e-39 3.75e-37
35 POSITIVE REGULATION OF LOCOMOTION 73 420 3.519e-39 4.679e-37
36 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 109 1036 2.607e-37 3.278e-35
37 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 109 1036 2.607e-37 3.278e-35
38 POSITIVE REGULATION OF CELL DIFFERENTIATION 97 823 3.594e-37 4.401e-35
39 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 107 1004 4.207e-37 5.019e-35
40 POSITIVE REGULATION OF MOLECULAR FUNCTION 145 1791 5.075e-37 5.904e-35
41 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 105 983 1.818e-36 2.063e-34
42 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 123 1360 1.179e-35 1.306e-33
43 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 105 1008 1.71e-35 1.85e-33
44 IMMUNE SYSTEM DEVELOPMENT 80 582 2.633e-35 2.785e-33
45 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 111 1135 4.58e-35 4.736e-33
46 IMMUNE RESPONSE 109 1100 6.405e-35 6.479e-33
47 DEFENSE RESPONSE 115 1231 1.643e-34 1.627e-32
48 REGULATION OF CELL ADHESION 82 629 1.717e-34 1.664e-32
49 RESPONSE TO ABIOTIC STIMULUS 104 1024 3.537e-34 3.359e-32
50 RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 60 321 4.435e-34 4.127e-32
51 NEGATIVE REGULATION OF CELL PROLIFERATION 82 643 8.641e-34 7.883e-32
52 CELL ACTIVATION 77 568 1.498e-33 1.341e-31
53 RESPONSE TO HORMONE 96 893 1.844e-33 1.619e-31
54 INFLAMMATORY RESPONSE 69 454 3.251e-33 2.801e-31
55 POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 94 867 4.86e-33 4.111e-31
56 RESPONSE TO WOUNDING 76 563 5.492e-33 4.563e-31
57 RESPONSE TO CYTOKINE 84 714 4.992e-32 4.075e-30
58 CARDIOVASCULAR SYSTEM DEVELOPMENT 88 788 7.471e-32 5.892e-30
59 CIRCULATORY SYSTEM DEVELOPMENT 88 788 7.471e-32 5.892e-30
60 NEGATIVE REGULATION OF CELL COMMUNICATION 109 1192 8.564e-32 6.642e-30
61 NEGATIVE REGULATION OF GENE EXPRESSION 122 1493 4.622e-31 3.525e-29
62 POSITIVE REGULATION OF CELL DEATH 76 605 7.369e-31 5.45e-29
63 RESPONSE TO BIOTIC STIMULUS 92 886 7.379e-31 5.45e-29
64 CELL DEATH 98 1001 7.744e-31 5.63e-29
65 REGULATION OF CYTOKINE PRODUCTION 73 563 1.555e-30 1.097e-28
66 WOUND HEALING 67 470 1.556e-30 1.097e-28
67 ORGAN MORPHOGENESIS 88 841 9.75e-30 6.771e-28
68 LEUKOCYTE MIGRATION 50 259 3.402e-29 2.328e-27
69 POSITIVE REGULATION OF CATALYTIC ACTIVITY 120 1518 3.505e-29 2.364e-27
70 RESPONSE TO BACTERIUM 69 528 4.438e-29 2.95e-27
71 RESPONSE TO NITROGEN COMPOUND 88 859 4.651e-29 3.048e-27
72 REGULATION OF TRANSPORT 132 1804 5.866e-29 3.791e-27
73 CELLULAR RESPONSE TO LIPID 64 457 9.893e-29 6.306e-27
74 LEUKOCYTE ACTIVATION 61 414 1.222e-28 7.684e-27
75 LEUKOCYTE DIFFERENTIATION 52 292 1.498e-28 9.295e-27
76 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 84 801 1.953e-28 1.195e-26
77 REGULATION OF CELL DEVELOPMENT 85 836 8.007e-28 4.839e-26
78 VASCULATURE DEVELOPMENT 63 469 2.951e-27 1.76e-25
79 LYMPHOCYTE ACTIVATION 54 342 6.226e-27 3.667e-25
80 REGULATION OF MAPK CASCADE 74 660 7.279e-27 4.234e-25
81 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 93 1021 7.482e-27 4.298e-25
82 EXTRACELLULAR STRUCTURE ORGANIZATION 51 304 9.528e-27 5.407e-25
83 EPITHELIUM DEVELOPMENT 89 945 1.021e-26 5.722e-25
84 RESPONSE TO STEROID HORMONE 64 497 1.244e-26 6.892e-25
85 INTRACELLULAR SIGNAL TRANSDUCTION 117 1572 4.334e-26 2.372e-24
86 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 87 926 4.913e-26 2.658e-24
87 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 98 1152 5.03e-26 2.69e-24
88 REGULATION OF KINASE ACTIVITY 79 776 6.955e-26 3.677e-24
89 BIOLOGICAL ADHESION 92 1032 7.17e-26 3.748e-24
90 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 77 740 7.732e-26 3.997e-24
91 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 114 1517 9.688e-26 4.954e-24
92 SINGLE ORGANISM CELL ADHESION 60 459 2.394e-25 1.211e-23
93 CELLULAR RESPONSE TO BIOTIC STIMULUS 37 163 1.78e-24 8.906e-23
94 POSITIVE REGULATION OF TRANSPORT 85 936 2.015e-24 9.972e-23
95 TISSUE MORPHOGENESIS 63 533 3.647e-24 1.786e-22
96 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 41 213 4.679e-24 2.268e-22
97 CELLULAR RESPONSE TO CYTOKINE STIMULUS 67 606 5.311e-24 2.548e-22
98 REGULATION OF PEPTIDASE ACTIVITY 54 392 5.523e-24 2.596e-22
99 RESPONSE TO ALCOHOL 52 362 5.517e-24 2.596e-22
100 REGULATION OF CELL CELL ADHESION 53 380 8.197e-24 3.814e-22
101 RESPONSE TO GROWTH FACTOR 59 475 8.917e-24 4.108e-22
102 LEUKOCYTE CELL CELL ADHESION 44 255 1.031e-23 4.704e-22
103 REGULATION OF HYDROLASE ACTIVITY 102 1327 1.134e-23 5.123e-22
104 NEUROGENESIS 105 1402 1.66e-23 7.426e-22
105 REGULATION OF TRANSFERASE ACTIVITY 84 946 1.754e-23 7.773e-22
106 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 58 465 1.776e-23 7.797e-22
107 POSITIVE REGULATION OF PEPTIDASE ACTIVITY 35 154 3.113e-23 1.354e-21
108 REGULATION OF DEFENSE RESPONSE 74 759 4.139e-23 1.783e-21
109 BLOOD VESSEL MORPHOGENESIS 51 364 4.897e-23 2.072e-21
110 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 90 1087 4.874e-23 2.072e-21
111 REGULATION OF RESPONSE TO WOUNDING 54 413 6.925e-23 2.903e-21
112 RESPONSE TO INORGANIC SUBSTANCE 58 479 8.01e-23 3.328e-21
113 MORPHOGENESIS OF AN EPITHELIUM 53 400 9.477e-23 3.868e-21
114 TAXIS 57 464 9.405e-23 3.868e-21
115 REGULATION OF CELL ACTIVATION 58 484 1.353e-22 5.474e-21
116 POSITIVE REGULATION OF CELL ADHESION 51 376 2.183e-22 8.68e-21
117 CELL DEVELOPMENT 104 1426 2.166e-22 8.68e-21
118 HOMEOSTATIC PROCESS 100 1337 2.603e-22 1.026e-20
119 PROTEIN PHOSPHORYLATION 82 944 2.63e-22 1.028e-20
120 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 69 689 3.156e-22 1.224e-20
121 AGING 43 264 3.575e-22 1.375e-20
122 REGULATION OF PROTEIN LOCALIZATION 82 950 3.949e-22 1.506e-20
123 REGULATION OF CELLULAR LOCALIZATION 97 1277 4.144e-22 1.568e-20
124 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 82 957 6.314e-22 2.369e-20
125 CELLULAR RESPONSE TO NITROGEN COMPOUND 58 505 1.134e-21 4.22e-20
126 PHOSPHORYLATION 94 1228 1.2e-21 4.431e-20
127 REGULATION OF GROWTH 65 633 1.504e-21 5.509e-20
128 REGULATION OF APOPTOTIC SIGNALING PATHWAY 49 363 1.881e-21 6.838e-20
129 GLAND DEVELOPMENT 51 395 2.06e-21 7.432e-20
130 POSITIVE REGULATION OF CYTOKINE PRODUCTION 49 370 4.347e-21 1.556e-19
131 NEGATIVE REGULATION OF CELL DIFFERENTIATION 63 609 4.52e-21 1.606e-19
132 POSITIVE REGULATION OF MAPK CASCADE 55 470 5.658e-21 1.995e-19
133 REGULATION OF PROTEOLYSIS 68 711 8.366e-21 2.927e-19
134 REGULATION OF IMMUNE RESPONSE 75 858 1.413e-20 4.906e-19
135 LYMPHOCYTE DIFFERENTIATION 37 209 1.657e-20 5.709e-19
136 RESPONSE TO DRUG 52 431 1.799e-20 6.155e-19
137 POSITIVE REGULATION OF KINASE ACTIVITY 55 482 1.859e-20 6.315e-19
138 CELL CELL ADHESION 62 608 1.993e-20 6.721e-19
139 REGULATION OF HOMOTYPIC CELL CELL ADHESION 44 307 2.13e-20 7.131e-19
140 SKELETAL SYSTEM DEVELOPMENT 53 455 3.775e-20 1.254e-18
141 INNATE IMMUNE RESPONSE 62 619 4.972e-20 1.641e-18
142 TUBE DEVELOPMENT 58 552 8.875e-20 2.908e-18
143 REPRODUCTION 93 1297 1.771e-19 5.761e-18
144 CELLULAR RESPONSE TO STRESS 104 1565 2.186e-19 7.063e-18
145 REGULATION OF EPITHELIAL CELL PROLIFERATION 41 285 3.857e-19 1.238e-17
146 REGULATION OF OSSIFICATION 33 178 4.664e-19 1.486e-17
147 EMBRYO DEVELOPMENT 74 894 5.951e-19 1.884e-17
148 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 52 470 8.544e-19 2.686e-17
149 RESPONSE TO OXYGEN LEVELS 42 311 1.542e-18 4.782e-17
150 POSITIVE REGULATION OF CELL ACTIVATION 42 311 1.542e-18 4.782e-17
151 REGULATION OF CYTOKINE SECRETION 30 149 1.708e-18 5.262e-17
152 REGULATION OF CELLULAR RESPONSE TO STRESS 63 691 2.86e-18 8.756e-17
153 HEART DEVELOPMENT 51 466 3.011e-18 9.157e-17
154 CELL PROLIFERATION 62 672 3.034e-18 9.167e-17
155 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 59 616 3.655e-18 1.097e-16
156 POSITIVE REGULATION OF HYDROLASE ACTIVITY 73 905 4.437e-18 1.323e-16
157 ANGIOGENESIS 40 293 7.072e-18 2.096e-16
158 ZYMOGEN ACTIVATION 26 112 8.03e-18 2.365e-16
159 REPRODUCTIVE SYSTEM DEVELOPMENT 47 408 8.852e-18 2.59e-16
160 CELLULAR RESPONSE TO HORMONE STIMULUS 55 552 9.444e-18 2.746e-16
161 OSSIFICATION 37 251 9.659e-18 2.792e-16
162 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 40 296 1.019e-17 2.928e-16
163 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 65 750 1.042e-17 2.976e-16
164 REGULATION OF NEURON DEATH 37 252 1.105e-17 3.117e-16
165 RESPONSE TO MECHANICAL STIMULUS 34 210 1.1e-17 3.117e-16
166 NEGATIVE REGULATION OF MOLECULAR FUNCTION 80 1079 1.316e-17 3.688e-16
167 REGULATION OF CELL CYCLE 74 949 1.662e-17 4.631e-16
168 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 24 95 1.819e-17 5.039e-16
169 RESPONSE TO METAL ION 42 333 1.967e-17 5.417e-16
170 REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 29 152 2.99e-17 8.183e-16
171 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 46 404 3.179e-17 8.65e-16
172 CHEMICAL HOMEOSTASIS 70 874 3.409e-17 9.221e-16
173 MORPHOGENESIS OF A BRANCHING STRUCTURE 30 167 4.863e-17 1.308e-15
174 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 115 1977 4.962e-17 1.327e-15
175 REGULATION OF NEURON DIFFERENTIATION 54 554 5.018e-17 1.334e-15
176 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 51 498 5.046e-17 1.334e-15
177 REGULATION OF HEMOPOIESIS 40 314 8.297e-17 2.181e-15
178 REGULATION OF SECRETION 61 699 8.372e-17 2.181e-15
179 POSITIVE REGULATION OF PROTEOLYSIS 43 363 8.389e-17 2.181e-15
180 T CELL DIFFERENTIATION 26 123 9.546e-17 2.468e-15
181 REGULATION OF BODY FLUID LEVELS 51 506 9.828e-17 2.526e-15
182 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 56 602 1.032e-16 2.637e-15
183 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 33 213 1.304e-16 3.316e-15
184 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 47 437 1.355e-16 3.426e-15
185 RESPONSE TO ACID CHEMICAL 40 319 1.445e-16 3.615e-15
186 REGULATION OF MAP KINASE ACTIVITY 40 319 1.445e-16 3.615e-15
187 RESPONSE TO OXIDATIVE STRESS 42 352 1.497e-16 3.724e-15
188 REGENERATION 29 161 1.514e-16 3.747e-15
189 POSITIVE REGULATION OF CELL CELL ADHESION 35 243 1.592e-16 3.919e-15
190 GLIOGENESIS 30 175 1.869e-16 4.576e-15
191 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 51 514 1.887e-16 4.597e-15
192 REGULATION OF INFLAMMATORY RESPONSE 38 294 3.094e-16 7.498e-15
193 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 61 724 4.369e-16 1.053e-14
194 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 26 131 4.884e-16 1.172e-14
195 POSITIVE REGULATION OF DEFENSE RESPONSE 42 364 5.014e-16 1.196e-14
196 CYTOKINE MEDIATED SIGNALING PATHWAY 47 452 5.06e-16 1.201e-14
197 REGULATION OF PROTEIN SECRETION 43 389 1.058e-15 2.498e-14
198 REGULATION OF LEUKOCYTE MIGRATION 27 149 1.462e-15 3.435e-14
199 CELL CHEMOTAXIS 28 162 1.544e-15 3.609e-14
200 REGULATION OF HOMEOSTATIC PROCESS 46 447 1.563e-15 3.635e-14
201 REGULATION OF INTRACELLULAR TRANSPORT 55 621 1.657e-15 3.837e-14
202 RESPONSE TO ESTROGEN 32 218 1.874e-15 4.316e-14
203 MUSCLE STRUCTURE DEVELOPMENT 45 432 2.054e-15 4.708e-14
204 PROTEIN MATURATION 35 265 2.439e-15 5.563e-14
205 REGULATION OF NEURON APOPTOTIC PROCESS 30 192 2.565e-15 5.822e-14
206 POSITIVE REGULATION OF CELL DEVELOPMENT 47 472 2.682e-15 6.058e-14
207 PEPTIDYL AMINO ACID MODIFICATION 65 841 2.907e-15 6.534e-14
208 GLAND MORPHOGENESIS 22 97 4.714e-15 1.054e-13
209 REGULATION OF CYTOPLASMIC TRANSPORT 47 481 5.506e-15 1.226e-13
210 POSITIVE REGULATION OF CHEMOTAXIS 24 120 5.533e-15 1.226e-13
211 POSITIVE REGULATION OF LEUKOCYTE MIGRATION 23 109 6.012e-15 1.326e-13
212 RESPONSE TO PURINE CONTAINING COMPOUND 27 158 6.675e-15 1.465e-13
213 TUBE MORPHOGENESIS 38 323 6.965e-15 1.521e-13
214 POSITIVE REGULATION OF IMMUNE RESPONSE 51 563 7.726e-15 1.68e-13
215 NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 30 200 7.965e-15 1.724e-13
216 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 27 162 1.266e-14 2.728e-13
217 RESPONSE TO CORTICOSTEROID 28 176 1.383e-14 2.965e-13
218 REGULATION OF CELL MORPHOGENESIS 50 552 1.447e-14 3.089e-13
219 CELLULAR HOMEOSTASIS 56 676 1.596e-14 3.392e-13
220 EPITHELIAL CELL DIFFERENTIATION 47 495 1.626e-14 3.439e-13
221 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 50 554 1.668e-14 3.512e-13
222 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 53 616 1.843e-14 3.863e-13
223 RESPONSE TO PEPTIDE 42 404 1.98e-14 4.13e-13
224 REGULATION OF CHEMOTAXIS 28 180 2.485e-14 5.161e-13
225 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 56 684 2.626e-14 5.431e-13
226 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 49 541 2.709e-14 5.553e-13
227 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 49 541 2.709e-14 5.553e-13
228 LEUKOCYTE CHEMOTAXIS 23 117 3.037e-14 6.199e-13
229 RESPONSE TO KETONE 28 182 3.31e-14 6.727e-13
230 NEGATIVE REGULATION OF CYTOKINE PRODUCTION 30 211 3.454e-14 6.987e-13
231 REGULATION OF INNATE IMMUNE RESPONSE 39 357 3.524e-14 7.098e-13
232 CELL FATE COMMITMENT 31 227 3.953e-14 7.927e-13
233 POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 27 171 4.988e-14 9.962e-13
234 REGULATION OF ORGANELLE ORGANIZATION 77 1178 5.33e-14 1.06e-12
235 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 47 513 6.158e-14 1.219e-12
236 ACTIVATION OF PROTEIN KINASE ACTIVITY 34 279 6.818e-14 1.344e-12
237 REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 39 365 7.251e-14 1.424e-12
238 CELLULAR RESPONSE TO EXTERNAL STIMULUS 33 264 7.741e-14 1.513e-12
239 RHYTHMIC PROCESS 35 298 8.807e-14 1.715e-12
240 NEGATIVE REGULATION OF PHOSPHORYLATION 42 422 8.853e-14 1.716e-12
241 CELLULAR RESPONSE TO ACID CHEMICAL 27 175 8.912e-14 1.721e-12
242 POSITIVE REGULATION OF RESPONSE TO WOUNDING 26 162 9.931e-14 1.909e-12
243 MESENCHYME DEVELOPMENT 28 190 1.004e-13 1.922e-12
244 REGULATION OF BINDING 34 283 1.036e-13 1.977e-12
245 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 39 370 1.126e-13 2.139e-12
246 POSITIVE REGULATION OF HEMOPOIESIS 26 163 1.153e-13 2.182e-12
247 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 24 138 1.446e-13 2.724e-12
248 CONNECTIVE TISSUE DEVELOPMENT 28 194 1.709e-13 3.207e-12
249 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 25 153 1.958e-13 3.659e-12
250 REGULATION OF CELLULAR PROTEIN LOCALIZATION 48 552 2.312e-13 4.303e-12
251 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 23 129 2.704e-13 5.013e-12
252 MULTI MULTICELLULAR ORGANISM PROCESS 29 213 2.886e-13 5.329e-12
253 EMBRYONIC MORPHOGENESIS 47 539 3.77e-13 6.933e-12
254 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 24 144 3.818e-13 6.994e-12
255 REGULATION OF VASCULATURE DEVELOPMENT 30 233 4.937e-13 9.008e-12
256 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 33 282 5.086e-13 9.245e-12
257 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 29 218 5.261e-13 9.526e-12
258 REGULATION OF SYSTEM PROCESS 45 507 6.625e-13 1.195e-11
259 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 36 337 6.882e-13 1.236e-11
260 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 20 98 6.998e-13 1.252e-11
261 CELLULAR COMPONENT MORPHOGENESIS 63 900 7.168e-13 1.278e-11
262 REGULATION OF LEUKOCYTE PROLIFERATION 28 206 7.788e-13 1.383e-11
263 POSITIVE REGULATION OF GROWTH 30 238 8.637e-13 1.528e-11
264 NEGATIVE REGULATION OF CELL CYCLE 41 433 9.145e-13 1.612e-11
265 SENSORY ORGAN DEVELOPMENT 44 493 1.002e-12 1.76e-11
266 REGULATION OF DEVELOPMENTAL GROWTH 33 289 1.014e-12 1.767e-11
267 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 33 289 1.014e-12 1.767e-11
268 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 20 100 1.045e-12 1.814e-11
269 REGULATION OF MUSCLE CELL DIFFERENTIATION 24 152 1.29e-12 2.232e-11
270 MUSCLE TISSUE DEVELOPMENT 32 275 1.348e-12 2.324e-11
271 POSITIVE REGULATION OF PROTEIN SECRETION 28 211 1.417e-12 2.434e-11
272 IN UTERO EMBRYONIC DEVELOPMENT 34 311 1.586e-12 2.703e-11
273 HEMOSTASIS 34 311 1.586e-12 2.703e-11
274 CENTRAL NERVOUS SYSTEM DEVELOPMENT 61 872 1.774e-12 3.012e-11
275 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 21 115 1.828e-12 3.093e-11
276 REGULATION OF PROTEIN IMPORT 26 183 1.84e-12 3.101e-11
277 REGULATION OF MUSCLE ORGAN DEVELOPMENT 20 103 1.871e-12 3.143e-11
278 NEGATIVE REGULATION OF CATALYTIC ACTIVITY 59 829 2.085e-12 3.489e-11
279 POSITIVE REGULATION OF PROTEIN IMPORT 20 104 2.261e-12 3.771e-11
280 REGULATION OF LEUKOCYTE DIFFERENTIATION 29 232 2.582e-12 4.276e-11
281 NEGATIVE REGULATION OF NEURON DEATH 25 171 2.576e-12 4.276e-11
282 REGULATION OF FAT CELL DIFFERENTIATION 20 106 3.281e-12 5.414e-11
283 RESPONSE TO RADIATION 39 413 3.656e-12 6.011e-11
284 POSITIVE REGULATION OF OSSIFICATION 18 84 4.149e-12 6.798e-11
285 REGULATION OF DNA METABOLIC PROCESS 35 340 4.23e-12 6.905e-11
286 PROTEOLYSIS 74 1208 4.285e-12 6.972e-11
287 STEM CELL DIFFERENTIATION 26 190 4.433e-12 7.186e-11
288 POSITIVE REGULATION OF CYTOKINE SECRETION 19 96 4.708e-12 7.606e-11
289 REGULATION OF PROTEIN KINASE B SIGNALING 21 121 5.102e-12 8.214e-11
290 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 24 162 5.302e-12 8.507e-11
291 NEGATIVE REGULATION OF CELL ADHESION 28 223 5.551e-12 8.875e-11
292 NEURON DIFFERENTIATION 60 874 6.015e-12 9.585e-11
293 COLLAGEN FIBRIL ORGANIZATION 13 38 6.241e-12 9.911e-11
294 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 18 86 6.345e-12 1.004e-10
295 GLIAL CELL DIFFERENTIATION 22 136 6.838e-12 1.079e-10
296 PLACENTA DEVELOPMENT 22 138 9.236e-12 1.452e-10
297 REGULATION OF CELLULAR COMPONENT BIOGENESIS 55 767 9.305e-12 1.458e-10
298 HEART MORPHOGENESIS 27 212 9.541e-12 1.49e-10
299 IMMUNE EFFECTOR PROCESS 42 486 9.586e-12 1.492e-10
300 CELLULAR CHEMICAL HOMEOSTASIS 46 570 1.015e-11 1.574e-10
301 RESPONSE TO ORGANOPHOSPHORUS 22 139 1.071e-11 1.656e-10
302 DEVELOPMENTAL GROWTH 34 333 1.085e-11 1.672e-10
303 CELLULAR RESPONSE TO ABIOTIC STIMULUS 30 263 1.144e-11 1.756e-10
304 GROWTH 38 410 1.225e-11 1.876e-10
305 PROTEIN COMPLEX SUBUNIT ORGANIZATION 85 1527 1.41e-11 2.151e-10
306 REGULATION OF MUSCLE TISSUE DEVELOPMENT 19 103 1.741e-11 2.647e-10
307 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 35 360 2.145e-11 3.252e-10
308 RESPONSE TO INTERFERON GAMMA 22 144 2.204e-11 3.329e-10
309 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 27 220 2.284e-11 3.44e-10
310 MUSCLE CELL DIFFERENTIATION 28 237 2.43e-11 3.647e-10
311 MYELOID CELL DIFFERENTIATION 25 189 2.45e-11 3.666e-10
312 REGULATION OF PROTEIN TARGETING 32 307 2.589e-11 3.862e-10
313 REGULATION OF ERK1 AND ERK2 CASCADE 28 238 2.688e-11 3.996e-10
314 RESPONSE TO EXTRACELLULAR STIMULUS 39 441 2.722e-11 4.033e-10
315 FAT CELL DIFFERENTIATION 19 106 2.948e-11 4.354e-10
316 POSITIVE REGULATION OF MAP KINASE ACTIVITY 26 207 3.186e-11 4.691e-10
317 EMBRYONIC ORGAN DEVELOPMENT 37 406 3.763e-11 5.523e-10
318 MESENCHYMAL CELL DIFFERENTIATION 21 134 3.843e-11 5.623e-10
319 REGULATION OF ORGAN MORPHOGENESIS 28 242 4.006e-11 5.843e-10
320 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 20 121 4.152e-11 6.038e-10
321 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 21 135 4.443e-11 6.44e-10
322 MYELOID LEUKOCYTE DIFFERENTIATION 18 96 4.475e-11 6.446e-10
323 REGULATION OF LEUKOCYTE CHEMOTAXIS 18 96 4.475e-11 6.446e-10
324 POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 27 228 5.252e-11 7.542e-10
325 UROGENITAL SYSTEM DEVELOPMENT 31 299 6.109e-11 8.746e-10
326 REGULATION OF MYELOID CELL DIFFERENTIATION 24 183 7.392e-11 1.055e-09
327 TISSUE REMODELING 17 87 7.825e-11 1.113e-09
328 REGULATION OF OSTEOBLAST DIFFERENTIATION 19 112 8.011e-11 1.136e-09
329 CELLULAR RESPONSE TO OXIDATIVE STRESS 24 184 8.298e-11 1.174e-09
330 REGULATION OF CHEMOKINE PRODUCTION 15 65 8.385e-11 1.179e-09
331 REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 15 65 8.385e-11 1.179e-09
332 AMEBOIDAL TYPE CELL MIGRATION 22 154 8.516e-11 1.194e-09
333 REGULATION OF STEM CELL DIFFERENTIATION 19 113 9.401e-11 1.314e-09
334 POSITIVE REGULATION OF BINDING 20 127 1.028e-10 1.432e-09
335 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 35 381 1.038e-10 1.442e-09
336 PEPTIDYL TYROSINE MODIFICATION 24 186 1.043e-10 1.445e-09
337 MULTI ORGANISM REPRODUCTIVE PROCESS 58 891 1.137e-10 1.57e-09
338 REGULATION OF METAL ION TRANSPORT 32 325 1.144e-10 1.575e-09
339 APOPTOTIC SIGNALING PATHWAY 30 289 1.214e-10 1.666e-09
340 EYE DEVELOPMENT 32 326 1.238e-10 1.695e-09
341 INTERSPECIES INTERACTION BETWEEN ORGANISMS 48 662 1.47e-10 2e-09
342 SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 48 662 1.47e-10 2e-09
343 REGULATION OF RESPONSE TO CYTOKINE STIMULUS 21 144 1.546e-10 2.097e-09
344 NEGATIVE REGULATION OF PROTEOLYSIS 32 329 1.568e-10 2.121e-09
345 HEAD DEVELOPMENT 50 709 1.573e-10 2.122e-09
346 HOMEOSTASIS OF NUMBER OF CELLS 23 175 1.765e-10 2.374e-09
347 POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 20 131 1.827e-10 2.45e-09
348 POSITIVE REGULATION OF SECRETION 34 370 1.917e-10 2.564e-09
349 CELLULAR RESPONSE TO MECHANICAL STIMULUS 16 80 1.961e-10 2.615e-09
350 MUSCLE ORGAN DEVELOPMENT 29 277 2.03e-10 2.699e-09
351 REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 19 118 2.04e-10 2.704e-09
352 REGULATION OF CELL GROWTH 35 391 2.108e-10 2.787e-09
353 REGULATION OF CELL PROJECTION ORGANIZATION 43 558 2.145e-10 2.827e-09
354 NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 34 372 2.214e-10 2.91e-09
355 CARTILAGE DEVELOPMENT 21 147 2.292e-10 3.003e-09
356 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 16 81 2.387e-10 3.111e-09
357 POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 16 81 2.387e-10 3.111e-09
358 RESPONSE TO TRANSITION METAL NANOPARTICLE 21 148 2.607e-10 3.388e-09
359 CYTOKINE PRODUCTION 19 120 2.749e-10 3.562e-09
360 REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 17 94 2.816e-10 3.64e-09
361 POSITIVE REGULATION OF INNATE IMMUNE RESPONSE 27 246 2.991e-10 3.855e-09
362 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 37 437 3.075e-10 3.933e-09
363 RESPONSE TO PROGESTERONE 13 50 3.076e-10 3.933e-09
364 LEUKOCYTE HOMEOSTASIS 14 60 3.063e-10 3.933e-09
365 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 24 197 3.479e-10 4.423e-09
366 POSITIVE REGULATION OF PROTEIN COMPLEX ASSEMBLY 24 197 3.479e-10 4.423e-09
367 ORGAN REGENERATION 16 83 3.502e-10 4.44e-09
368 CELLULAR RESPONSE TO INTERFERON GAMMA 19 122 3.681e-10 4.654e-09
369 CARDIOCYTE DIFFERENTIATION 17 96 3.974e-10 5.011e-09
370 POSITIVE REGULATION OF HOMEOSTATIC PROCESS 25 216 4.471e-10 5.623e-09
371 NEGATIVE REGULATION OF CELL CELL ADHESION 20 138 4.746e-10 5.952e-09
372 POSITIVE REGULATION OF NEURON DIFFERENTIATION 30 306 4.898e-10 6.126e-09
373 ENDOCYTOSIS 40 509 5.304e-10 6.617e-09
374 POSITIVE REGULATION OF DNA METABOLIC PROCESS 23 185 5.424e-10 6.748e-09
375 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 25 218 5.439e-10 6.749e-09
376 CELL CYCLE ARREST 21 154 5.525e-10 6.837e-09
377 CELL CYCLE PROCESS 64 1081 5.787e-10 7.143e-09
378 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 26 236 5.904e-10 7.267e-09
379 ACTIVATION OF IMMUNE RESPONSE 36 427 6.047e-10 7.423e-09
380 REGULATION OF WNT SIGNALING PATHWAY 30 310 6.697e-10 8.2e-09
381 BONE DEVELOPMENT 21 156 7.038e-10 8.573e-09
382 CELLULAR RESPONSE TO INORGANIC SUBSTANCE 21 156 7.038e-10 8.573e-09
383 ACTIVATION OF INNATE IMMUNE RESPONSE 24 204 7.159e-10 8.698e-09
384 POSITIVE REGULATION OF INFLAMMATORY RESPONSE 18 113 7.341e-10 8.896e-09
385 PLATELET ACTIVATION 20 142 7.968e-10 9.63e-09
386 MULTICELLULAR ORGANISM REPRODUCTION 51 768 8.348e-10 1.005e-08
387 POSITIVE REGULATION OF CELL CYCLE 31 332 8.357e-10 1.005e-08
388 NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 88 8.7e-10 1.041e-08
389 POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 16 88 8.7e-10 1.041e-08
390 EXTRACELLULAR MATRIX DISASSEMBLY 15 76 8.835e-10 1.054e-08
391 REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 17 101 9.045e-10 1.076e-08
392 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 24 207 9.658e-10 1.146e-08
393 RESPONSE TO INTERLEUKIN 1 18 115 9.852e-10 1.166e-08
394 RESPONSE TO REACTIVE OXYGEN SPECIES 23 191 1.025e-09 1.21e-08
395 REGULATION OF PROTEIN COMPLEX ASSEMBLY 33 375 1.085e-09 1.278e-08
396 RESPONSE TO IONIZING RADIATION 20 145 1.161e-09 1.361e-08
397 NEGATIVE REGULATION OF MAPK CASCADE 20 145 1.161e-09 1.361e-08
398 REGULATION OF CALCIUM ION TRANSPORT 24 209 1.175e-09 1.374e-08
399 REGULATION OF CYTOSKELETON ORGANIZATION 39 502 1.221e-09 1.424e-08
400 MAMMARY GLAND DEVELOPMENT 18 117 1.314e-09 1.528e-08
401 CELL CYCLE 72 1316 1.382e-09 1.603e-08
402 REGULATION OF LIPID METABOLIC PROCESS 28 282 1.405e-09 1.627e-08
403 SKIN DEVELOPMENT 24 211 1.427e-09 1.648e-08
404 RESPONSE TO CAMP 17 104 1.446e-09 1.666e-08
405 CELL AGING 14 67 1.463e-09 1.681e-08
406 REGULATION OF T CELL PROLIFERATION 20 147 1.484e-09 1.701e-08
407 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 25 229 1.534e-09 1.754e-08
408 BONE MORPHOGENESIS 15 79 1.561e-09 1.78e-08
409 POSITIVE REGULATION OF CELL GROWTH 20 148 1.675e-09 1.901e-08
410 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 29 303 1.675e-09 1.901e-08
411 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 14 68 1.799e-09 2.037e-08
412 REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 11 38 2.064e-09 2.332e-08
413 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 34 406 2.184e-09 2.461e-08
414 REGULATION OF INTERLEUKIN 1 PRODUCTION 13 58 2.263e-09 2.537e-08
415 ADAPTIVE IMMUNE RESPONSE 28 288 2.26e-09 2.537e-08
416 POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 19 136 2.431e-09 2.719e-08
417 REGULATION OF NEURON PROJECTION DEVELOPMENT 34 408 2.478e-09 2.765e-08
418 REGULATION OF ANATOMICAL STRUCTURE SIZE 37 472 2.583e-09 2.876e-08
419 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 18 122 2.627e-09 2.917e-08
420 REGULATION OF PROTEIN BINDING 21 168 2.778e-09 3.07e-08
421 RESPONSE TO CARBOHYDRATE 21 168 2.778e-09 3.07e-08
422 ENDOCRINE SYSTEM DEVELOPMENT 18 123 3.004e-09 3.312e-08
423 PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 17 109 3.048e-09 3.353e-08
424 POSITIVE REGULATION OF CHEMOKINE PRODUCTION 12 49 3.166e-09 3.474e-08
425 FORMATION OF PRIMARY GERM LAYER 17 110 3.52e-09 3.851e-08
426 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 13 60 3.534e-09 3.851e-08
427 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 13 60 3.534e-09 3.851e-08
428 NEGATIVE REGULATION OF TRANSPORT 36 458 3.973e-09 4.319e-08
429 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 12 50 4.068e-09 4.412e-08
430 REGULATION OF ION TRANSPORT 42 592 4.18e-09 4.524e-08
431 REGULATION OF WOUND HEALING 18 126 4.457e-09 4.812e-08
432 RESPONSE TO VITAMIN 16 98 4.486e-09 4.831e-08
433 RESPONSE TO AMINO ACID 17 112 4.672e-09 5.02e-08
434 POSITIVE REGULATION OF STAT CASCADE 14 73 4.794e-09 5.127e-08
435 POSITIVE REGULATION OF JAK STAT CASCADE 14 73 4.794e-09 5.127e-08
436 EXTRINSIC APOPTOTIC SIGNALING PATHWAY 16 99 5.224e-09 5.575e-08
437 REGULATION OF VITAMIN METABOLIC PROCESS 7 12 5.387e-09 5.735e-08
438 RESPONSE TO NUTRIENT 22 191 5.481e-09 5.822e-08
439 MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 6.299e-09 6.586e-08
440 ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 6.299e-09 6.586e-08
441 VIRAL ENTRY INTO HOST CELL 15 87 6.299e-09 6.586e-08
442 ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION 15 87 6.299e-09 6.586e-08
443 MOVEMENT IN HOST ENVIRONMENT 15 87 6.299e-09 6.586e-08
444 ENTRY INTO HOST 15 87 6.299e-09 6.586e-08
445 ENTRY INTO HOST CELL 15 87 6.299e-09 6.586e-08
446 CELL CELL SIGNALING 49 767 6.469e-09 6.749e-08
447 REGULATION OF CARTILAGE DEVELOPMENT 13 63 6.669e-09 6.942e-08
448 POSITIVE REGULATION OF DNA BINDING 11 42 6.685e-09 6.944e-08
449 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 14 75 6.931e-09 7.183e-08
450 NEGATIVE REGULATION OF CELL DEVELOPMENT 28 303 6.991e-09 7.229e-08
451 REGULATION OF MITOTIC CELL CYCLE 36 468 7.01e-09 7.232e-08
452 CELLULAR RESPONSE TO ALCOHOL 17 115 7.059e-09 7.266e-08
453 RESPONSE TO VIRUS 25 247 7.307e-09 7.506e-08
454 REGULATION OF MUSCLE SYSTEM PROCESS 22 195 8.067e-09 8.268e-08
455 RESPONSE TO ESTRADIOL 19 146 8.094e-09 8.277e-08
456 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 16 102 8.159e-09 8.325e-08
457 REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 12 53 8.329e-09 8.48e-08
458 CIRCULATORY SYSTEM PROCESS 31 366 8.689e-09 8.827e-08
459 REGULATION OF LYMPHOCYTE DIFFERENTIATION 18 132 9.477e-09 9.607e-08
460 NEGATIVE REGULATION OF MITOTIC CELL CYCLE 22 199 1.175e-08 1.189e-07
461 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 15 92 1.392e-08 1.405e-07
462 MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS 14 79 1.399e-08 1.409e-07
463 CELLULAR RESPONSE TO PEPTIDE 26 274 1.407e-08 1.411e-07
464 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 26 274 1.407e-08 1.411e-07
465 REGULATION OF ION HOMEOSTASIS 22 201 1.413e-08 1.414e-07
466 POSITIVE REGULATION OF NEURON DEATH 13 67 1.47e-08 1.465e-07
467 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 13 67 1.47e-08 1.465e-07
468 REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 11 45 1.478e-08 1.469e-07
469 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 17 121 1.549e-08 1.537e-07
470 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 40 573 1.556e-08 1.541e-07
471 DEFENSE RESPONSE TO OTHER ORGANISM 37 505 1.568e-08 1.549e-07
472 MULTICELLULAR ORGANISM METABOLIC PROCESS 15 93 1.62e-08 1.597e-07
473 NEGATIVE REGULATION OF HYDROLASE ACTIVITY 32 397 1.637e-08 1.61e-07
474 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 14 80 1.656e-08 1.625e-07
475 ION HOMEOSTASIS 40 576 1.798e-08 1.761e-07
476 CELLULAR RESPONSE TO DNA DAMAGE STIMULUS 46 720 1.929e-08 1.886e-07
477 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 19 154 1.967e-08 1.919e-07
478 RESPONSE TO HYDROGEN PEROXIDE 16 109 2.171e-08 2.114e-07
479 INOSITOL LIPID MEDIATED SIGNALING 17 124 2.253e-08 2.188e-07
480 POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 20 172 2.312e-08 2.241e-07
481 STRIATED MUSCLE CELL DIFFERENTIATION 20 173 2.552e-08 2.469e-07
482 INTERFERON GAMMA MEDIATED SIGNALING PATHWAY 13 70 2.562e-08 2.473e-07
483 CELLULAR COMPONENT DISASSEMBLY 37 515 2.615e-08 2.519e-07
484 NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 24 245 2.76e-08 2.653e-07
485 NEGATIVE REGULATION OF CELL ACTIVATION 19 158 2.999e-08 2.878e-07
486 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 11 48 3.065e-08 2.935e-07
487 CHONDROCYTE DIFFERENTIATION 12 60 3.704e-08 3.539e-07
488 REGULATION OF JAK STAT CASCADE 18 144 3.784e-08 3.601e-07
489 REGULATION OF STAT CASCADE 18 144 3.784e-08 3.601e-07
490 CYTOSKELETON ORGANIZATION 50 838 4.042e-08 3.838e-07
491 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 18 145 4.218e-08 3.989e-07
492 REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 18 145 4.218e-08 3.989e-07
493 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 23 232 4.308e-08 4.066e-07
494 ACUTE INFLAMMATORY RESPONSE 13 73 4.337e-08 4.077e-07
495 REGULATION OF ORGAN GROWTH 13 73 4.337e-08 4.077e-07
496 REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 23 233 4.666e-08 4.368e-07
497 RESPONSE TO TUMOR NECROSIS FACTOR 23 233 4.666e-08 4.368e-07
498 LYMPHOCYTE HOMEOSTASIS 11 50 4.835e-08 4.518e-07
499 REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 15 101 5.101e-08 4.757e-07
500 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 74 5.139e-08 4.782e-07
501 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 12 62 5.455e-08 5.066e-07
502 POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 17 132 5.792e-08 5.368e-07
503 NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 15 102 5.84e-08 5.402e-07
504 NEGATIVE REGULATION OF GROWTH 23 236 5.913e-08 5.459e-07
505 REGULATION OF INTERLEUKIN 12 PRODUCTION 11 51 6.022e-08 5.549e-07
506 LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 9 31 6.036e-08 5.551e-07
507 DEFENSE RESPONSE TO BACTERIUM 23 237 6.393e-08 5.867e-07
508 CELL PROJECTION ORGANIZATION 52 902 6.447e-08 5.905e-07
509 REGULATION OF EPIDERMIS DEVELOPMENT 12 63 6.581e-08 6.016e-07
510 SKELETAL SYSTEM MORPHOGENESIS 21 201 6.782e-08 6.187e-07
511 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 10 41 6.911e-08 6.293e-07
512 INTERACTION WITH HOST 17 134 7.251e-08 6.589e-07
513 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 24 258 7.416e-08 6.726e-07
514 TISSUE REGENERATION 11 52 7.461e-08 6.741e-07
515 POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 11 52 7.461e-08 6.741e-07
516 REGULATION OF IMMUNE EFFECTOR PROCESS 32 424 7.626e-08 6.863e-07
517 REGULATION OF INTERLEUKIN 6 PRODUCTION 15 104 7.616e-08 6.863e-07
518 REGULATION OF OXIDOREDUCTASE ACTIVITY 14 90 7.826e-08 7.03e-07
519 NEGATIVE REGULATION OF CATABOLIC PROCESS 21 203 8.046e-08 7.214e-07
520 REGULATION OF CATABOLIC PROCESS 45 731 8.207e-08 7.344e-07
521 EPITHELIAL CELL DEVELOPMENT 20 186 8.644e-08 7.719e-07
522 RESPONSE TO ETHANOL 17 136 9.038e-08 8.056e-07
523 POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 11 53 9.197e-08 8.167e-07
524 CELLULAR RESPONSE TO AMINO ACID STIMULUS 11 53 9.197e-08 8.167e-07
525 GLUCOSE HOMEOSTASIS 19 170 9.819e-08 8.686e-07
526 CARBOHYDRATE HOMEOSTASIS 19 170 9.819e-08 8.686e-07
527 POSITIVE REGULATION OF CALCIUM ION TRANSPORT 15 106 9.869e-08 8.714e-07
528 DIVALENT INORGANIC CATION HOMEOSTASIS 28 343 1.002e-07 8.829e-07
529 CIRCADIAN RHYTHM 17 137 1.007e-07 8.861e-07
530 NEURON PROJECTION DEVELOPMENT 37 545 1.112e-07 9.759e-07
531 ALPHA BETA T CELL ACTIVATION 11 54 1.128e-07 9.886e-07
532 SYSTEM PROCESS 83 1785 1.165e-07 1.019e-06
533 REGULATION OF DNA BINDING 14 93 1.196e-07 1.044e-06
534 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 20 190 1.23e-07 1.072e-06
535 CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 17 139 1.248e-07 1.085e-06
536 POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 13 80 1.343e-07 1.166e-06
537 TELENCEPHALON DEVELOPMENT 22 228 1.368e-07 1.185e-06
538 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 11 55 1.378e-07 1.189e-06
539 REGULATION OF KIDNEY DEVELOPMENT 11 55 1.378e-07 1.189e-06
540 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 9 34 1.465e-07 1.263e-06
541 POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 13 81 1.562e-07 1.343e-06
542 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 14 95 1.572e-07 1.349e-06
543 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 11 56 1.675e-07 1.432e-06
544 OUTFLOW TRACT MORPHOGENESIS 11 56 1.675e-07 1.432e-06
545 ALPHA BETA T CELL DIFFERENTIATION 10 45 1.792e-07 1.53e-06
546 EAR DEVELOPMENT 20 195 1.885e-07 1.606e-06
547 NEGATIVE REGULATION OF OSSIFICATION 12 69 1.888e-07 1.606e-06
548 REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 11 57 2.027e-07 1.718e-06
549 ENDOTHELIAL CELL MIGRATION 11 57 2.027e-07 1.718e-06
550 EPIDERMIS DEVELOPMENT 23 253 2.101e-07 1.777e-06
551 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 16 128 2.159e-07 1.823e-06
552 RESPIRATORY SYSTEM DEVELOPMENT 20 197 2.227e-07 1.871e-06
553 POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING 19 179 2.227e-07 1.871e-06
554 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 20 197 2.227e-07 1.871e-06
555 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 46 2.237e-07 1.872e-06
556 REGULATION OF CHONDROCYTE DIFFERENTIATION 10 46 2.237e-07 1.872e-06
557 NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 18 162 2.329e-07 1.946e-06
558 LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 14 98 2.337e-07 1.948e-06
559 TISSUE MIGRATION 13 84 2.426e-07 2.019e-06
560 CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 11 58 2.444e-07 2.027e-06
561 UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 11 58 2.444e-07 2.027e-06
562 REGULATION OF ERYTHROCYTE DIFFERENTIATION 9 36 2.511e-07 2.075e-06
563 REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 9 36 2.511e-07 2.075e-06
564 REGULATION OF ENDOCYTOSIS 20 199 2.625e-07 2.166e-06
565 THYMUS DEVELOPMENT 10 47 2.776e-07 2.286e-06
566 REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 13 85 2.797e-07 2.295e-06
567 TOLL LIKE RECEPTOR SIGNALING PATHWAY 13 85 2.797e-07 2.295e-06
568 POSITIVE REGULATION OF DNA REPLICATION 13 86 3.218e-07 2.636e-06
569 GLIAL CELL MIGRATION 9 37 3.242e-07 2.652e-06
570 MAINTENANCE OF CELL NUMBER 16 132 3.312e-07 2.704e-06
571 POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 10 48 3.426e-07 2.792e-06
572 POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 12 73 3.583e-07 2.915e-06
573 NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 29 387 3.634e-07 2.951e-06
574 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 16 133 3.677e-07 2.98e-06
575 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 23 262 3.921e-07 3.173e-06
576 CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 12 74 4.177e-07 3.361e-06
577 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 11 61 4.183e-07 3.361e-06
578 REGULATION OF INTERLEUKIN 8 PRODUCTION 11 61 4.183e-07 3.361e-06
579 CARDIAC MUSCLE CELL DIFFERENTIATION 12 74 4.177e-07 3.361e-06
580 REGULATION OF STEROID BIOSYNTHETIC PROCESS 10 49 4.205e-07 3.368e-06
581 LYMPHOCYTE MIGRATION 10 49 4.205e-07 3.368e-06
582 CELLULAR RESPONSE TO INTERLEUKIN 1 13 88 4.234e-07 3.369e-06
583 REGULATION OF COAGULATION 13 88 4.234e-07 3.369e-06
584 RESPONSE TO INSULIN 20 205 4.243e-07 3.369e-06
585 REGULATION OF STEM CELL PROLIFERATION 13 88 4.234e-07 3.369e-06
586 NEURON PROJECTION GUIDANCE 20 205 4.243e-07 3.369e-06
587 NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS 6 13 4.361e-07 3.457e-06
588 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 14 103 4.377e-07 3.464e-06
589 PARTURITION 7 20 4.4e-07 3.47e-06
590 REGULATION OF MONOCYTE CHEMOTAXIS 7 20 4.4e-07 3.47e-06
591 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 19 188 4.789e-07 3.77e-06
592 ARTERY DEVELOPMENT 12 75 4.857e-07 3.805e-06
593 EPITHELIAL CELL PROLIFERATION 13 89 4.842e-07 3.805e-06
594 NEURAL CREST CELL DIFFERENTIATION 12 75 4.857e-07 3.805e-06
595 CARDIAC CHAMBER MORPHOGENESIS 14 104 4.939e-07 3.856e-06
596 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 14 104 4.939e-07 3.856e-06
597 EYE MORPHOGENESIS 16 136 4.998e-07 3.895e-06
598 PALLIUM DEVELOPMENT 17 153 5.031e-07 3.914e-06
599 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 10 50 5.135e-07 3.969e-06
600 STAT CASCADE 10 50 5.135e-07 3.969e-06
601 JAK STAT CASCADE 10 50 5.135e-07 3.969e-06
602 RESPONSE TO GAMMA RADIATION 10 50 5.135e-07 3.969e-06
603 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 8 29 5.173e-07 3.979e-06
604 REGULATION OF HEART MORPHOGENESIS 8 29 5.173e-07 3.979e-06
605 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 8 29 5.173e-07 3.979e-06
606 REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 9 39 5.274e-07 4.043e-06
607 ASTROCYTE DIFFERENTIATION 9 39 5.274e-07 4.043e-06
608 NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 27 351 5.531e-07 4.233e-06
609 ODONTOGENESIS 14 105 5.566e-07 4.253e-06
610 GASTRULATION 17 155 6.055e-07 4.619e-06
611 ENDOCRINE PANCREAS DEVELOPMENT 9 40 6.65e-07 5.039e-06
612 ENDODERMAL CELL DIFFERENTIATION 9 40 6.65e-07 5.039e-06
613 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 17 156 6.636e-07 5.039e-06
614 NEGATIVE REGULATION OF RESPONSE TO WOUNDING 17 156 6.636e-07 5.039e-06
615 REGULATION OF PHOSPHOLIPASE ACTIVITY 11 64 6.934e-07 5.246e-06
616 REGULATION OF SEQUESTERING OF CALCIUM ION 14 107 7.037e-07 5.307e-06
617 REGULATION OF T CELL DIFFERENTIATION 14 107 7.037e-07 5.307e-06
618 NEURON DEVELOPMENT 41 687 7.09e-07 5.338e-06
619 POSITIVE REGULATION OF MITOTIC CELL CYCLE 15 123 7.125e-07 5.356e-06
620 BEHAVIOR 34 516 7.295e-07 5.475e-06
621 CARDIAC MUSCLE TISSUE DEVELOPMENT 16 140 7.425e-07 5.563e-06
622 POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 6 14 7.464e-07 5.566e-06
623 T CELL MIGRATION 6 14 7.464e-07 5.566e-06
624 POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 6 14 7.464e-07 5.566e-06
625 RENAL TUBULE DEVELOPMENT 12 78 7.525e-07 5.602e-06
626 FOREBRAIN DEVELOPMENT 27 357 7.7e-07 5.723e-06
627 NEURON PROJECTION MORPHOGENESIS 29 402 7.948e-07 5.898e-06
628 POSITIVE REGULATION OF BLOOD CIRCULATION 13 93 8.134e-07 6.026e-06
629 CELLULAR RESPONSE TO RETINOIC ACID 11 65 8.154e-07 6.032e-06
630 MEMBRANE ORGANIZATION 49 899 8.244e-07 6.088e-06
631 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 41 8.326e-07 6.11e-06
632 AORTA DEVELOPMENT 9 41 8.326e-07 6.11e-06
633 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 9 41 8.326e-07 6.11e-06
634 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 9 41 8.326e-07 6.11e-06
635 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 12 79 8.667e-07 6.351e-06
636 REGULATION OF JNK CASCADE 17 159 8.692e-07 6.359e-06
637 REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 7 22 9.254e-07 6.728e-06
638 REGULATION OF RESPONSE TO INTERFERON GAMMA 7 22 9.254e-07 6.728e-06
639 REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 7 22 9.254e-07 6.728e-06
640 AORTA MORPHOGENESIS 7 22 9.254e-07 6.728e-06
641 OSTEOBLAST DIFFERENTIATION 15 126 9.736e-07 7.067e-06
642 SINGLE ORGANISM BEHAVIOR 28 384 9.97e-07 7.226e-06
643 POSITIVE REGULATION OF ION TRANSPORT 21 236 1.005e-06 7.275e-06
644 REGULATION OF HEART GROWTH 9 42 1.035e-06 7.478e-06
645 REGULATION OF DNA REPLICATION 17 161 1.037e-06 7.478e-06
646 POSITIVE REGULATION OF T CELL PROLIFERATION 13 95 1.043e-06 7.513e-06
647 POSITIVE REGULATION OF CALCIUM ION IMPORT 10 54 1.09e-06 7.84e-06
648 REGULATION OF FIBROBLAST PROLIFERATION 12 81 1.142e-06 8.2e-06
649 EMBRYONIC ORGAN MORPHOGENESIS 23 279 1.178e-06 8.442e-06
650 SALIVARY GLAND DEVELOPMENT 8 32 1.184e-06 8.448e-06
651 POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 8 32 1.184e-06 8.448e-06
652 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 32 1.184e-06 8.448e-06
653 REGULATION OF LIPID BIOSYNTHETIC PROCESS 15 128 1.192e-06 8.497e-06
654 NEGATIVE REGULATION OF SECRETION 19 200 1.234e-06 8.755e-06
655 SENSORY ORGAN MORPHOGENESIS 21 239 1.234e-06 8.755e-06
656 VASCULAR PROCESS IN CIRCULATORY SYSTEM 17 163 1.233e-06 8.755e-06
657 PROTEIN COMPLEX BIOGENESIS 57 1132 1.277e-06 9.022e-06
658 REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 9 43 1.28e-06 9.022e-06
659 PROTEIN COMPLEX ASSEMBLY 57 1132 1.277e-06 9.022e-06
660 ACUTE PHASE RESPONSE 9 43 1.28e-06 9.022e-06
661 REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 10 55 1.302e-06 9.096e-06
662 RESPONSE TO INCREASED OXYGEN LEVELS 7 23 1.301e-06 9.096e-06
663 CRANIAL SKELETAL SYSTEM DEVELOPMENT 10 55 1.302e-06 9.096e-06
664 LEUKOCYTE APOPTOTIC PROCESS 7 23 1.301e-06 9.096e-06
665 RESPONSE TO HYPEROXIA 7 23 1.301e-06 9.096e-06
666 POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 11 68 1.302e-06 9.096e-06
667 KIDNEY MORPHOGENESIS 12 82 1.307e-06 9.115e-06
668 RESPONSE TO TOXIC SUBSTANCE 21 241 1.412e-06 9.838e-06
669 REGULATION OF MUSCLE CONTRACTION 16 147 1.434e-06 9.971e-06
670 EMBRYONIC PLACENTA DEVELOPMENT 12 83 1.492e-06 1.036e-05
671 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 13 98 1.497e-06 1.038e-05
672 POSITIVE REGULATION OF AXONOGENESIS 11 69 1.513e-06 1.048e-05
673 CELLULAR SENESCENCE 8 33 1.527e-06 1.056e-05
674 POSITIVE REGULATION OF ENDOCYTOSIS 14 114 1.532e-06 1.058e-05
675 EPITHELIAL TO MESENCHYMAL TRANSITION 10 56 1.548e-06 1.067e-05
676 PEPTIDYL SERINE MODIFICATION 16 148 1.57e-06 1.077e-05
677 DIGESTIVE SYSTEM DEVELOPMENT 16 148 1.57e-06 1.077e-05
678 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 9 44 1.572e-06 1.077e-05
679 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 9 44 1.572e-06 1.077e-05
680 MYELOID LEUKOCYTE MIGRATION 13 99 1.683e-06 1.15e-05
681 LIPID PHOSPHORYLATION 13 99 1.683e-06 1.15e-05
682 POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 12 84 1.7e-06 1.16e-05
683 NEPHRON DEVELOPMENT 14 115 1.704e-06 1.161e-05
684 CIRCADIAN REGULATION OF GENE EXPRESSION 10 57 1.835e-06 1.246e-05
685 POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 10 57 1.835e-06 1.246e-05
686 INTRACELLULAR RECEPTOR SIGNALING PATHWAY 17 168 1.878e-06 1.274e-05
687 EXOCRINE SYSTEM DEVELOPMENT 9 45 1.92e-06 1.301e-05
688 POSITIVE REGULATION OF CELL CYCLE ARREST 12 85 1.934e-06 1.308e-05
689 PROTEIN KINASE B SIGNALING 8 34 1.952e-06 1.316e-05
690 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 8 34 1.952e-06 1.316e-05
691 INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 11 71 2.027e-06 1.365e-05
692 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 19 208 2.224e-06 1.495e-05
693 VESICLE MEDIATED TRANSPORT 60 1239 2.316e-06 1.555e-05
694 NEGATIVE REGULATION OF CYTOKINE SECRETION 9 46 2.333e-06 1.564e-05
695 CHEMOKINE MEDIATED SIGNALING PATHWAY 11 72 2.337e-06 1.565e-05
696 NEGATIVE REGULATION OF PROTEIN PROCESSING 8 35 2.473e-06 1.651e-05
697 NEGATIVE REGULATION OF PROTEIN MATURATION 8 35 2.473e-06 1.651e-05
698 NEGATIVE REGULATION OF KINASE ACTIVITY 21 250 2.541e-06 1.694e-05
699 REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 10 59 2.548e-06 1.696e-05
700 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 18 191 2.631e-06 1.749e-05
701 REGULATION OF CALCIUM ION IMPORT 13 103 2.649e-06 1.758e-05
702 ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 16 154 2.659e-06 1.762e-05
703 CELLULAR RESPONSE TO KETONE 11 73 2.689e-06 1.777e-05
704 REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 11 73 2.689e-06 1.777e-05
705 MYELOID CELL HOMEOSTASIS 12 88 2.813e-06 1.856e-05
706 POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 9 47 2.82e-06 1.856e-05
707 POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 9 47 2.82e-06 1.856e-05
708 SKELETAL MUSCLE ORGAN DEVELOPMENT 15 137 2.829e-06 1.856e-05
709 ACTIVATION OF MAPK ACTIVITY 15 137 2.829e-06 1.856e-05
710 NEGATIVE REGULATION OF ANOIKIS 6 17 2.878e-06 1.881e-05
711 POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 17 2.878e-06 1.881e-05
712 NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 6 17 2.878e-06 1.881e-05
713 REGULATION OF SMOOTH MUSCLE CONTRACTION 10 60 2.987e-06 1.95e-05
714 NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 8 36 3.108e-06 2.023e-05
715 T CELL SELECTION 8 36 3.108e-06 2.023e-05
716 NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 16 156 3.15e-06 2.041e-05
717 REGULATION OF B CELL ACTIVATION 14 121 3.144e-06 2.041e-05
718 POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 16 156 3.15e-06 2.041e-05
719 RESPONSE TO HEAT 12 89 3.176e-06 2.053e-05
720 B CELL DIFFERENTIATION 12 89 3.176e-06 2.053e-05
721 DEVELOPMENTAL PROGRAMMED CELL DEATH 7 26 3.262e-06 2.105e-05
722 CEREBRAL CORTEX DEVELOPMENT 13 105 3.296e-06 2.124e-05
723 REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 9 48 3.392e-06 2.183e-05
724 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 11 75 3.532e-06 2.27e-05
725 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 90 3.58e-06 2.294e-05
726 MESONEPHROS DEVELOPMENT 12 90 3.58e-06 2.294e-05
727 REGULATION OF ADAPTIVE IMMUNE RESPONSE 14 123 3.823e-06 2.447e-05
728 MYOBLAST DIFFERENTIATION 8 37 3.877e-06 2.474e-05
729 POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT3 PROTEIN 8 37 3.877e-06 2.474e-05
730 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 9 49 4.06e-06 2.588e-05
731 RESPONSE TO RETINOIC ACID 13 107 4.08e-06 2.597e-05
732 REGULATION OF CELL CYCLE PROCESS 34 558 4.129e-06 2.625e-05
733 RESPONSE TO PLATELET DERIVED GROWTH FACTOR 6 18 4.223e-06 2.681e-05
734 DETECTION OF BIOTIC STIMULUS 7 27 4.305e-06 2.725e-05
735 REGULATION OF CATENIN IMPORT INTO NUCLEUS 7 27 4.305e-06 2.725e-05
736 REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 22 280 4.398e-06 2.78e-05
737 REGULATION OF CELL CYCLE ARREST 13 108 4.53e-06 2.86e-05
738 REGULATION OF BMP SIGNALING PATHWAY 11 77 4.598e-06 2.899e-05
739 KIDNEY EPITHELIUM DEVELOPMENT 14 125 4.628e-06 2.914e-05
740 POSITIVE REGULATION OF HAIR CYCLE 5 11 4.686e-06 2.947e-05
741 REGULATION OF MUSCLE ADAPTATION 10 63 4.724e-06 2.966e-05
742 LYMPHOCYTE CHEMOTAXIS 8 38 4.8e-06 3.01e-05
743 CELLULAR RESPONSE TO OXYGEN LEVELS 15 143 4.831e-06 3.025e-05
744 ENDODERM FORMATION 9 50 4.839e-06 3.026e-05
745 SECRETION 35 588 4.985e-06 3.113e-05
746 NEPHRON EPITHELIUM DEVELOPMENT 12 93 5.074e-06 3.165e-05
747 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 14 126 5.085e-06 3.167e-05
748 POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 10 64 5.47e-06 3.403e-05
749 RESPONSE TO COPPER ION 7 28 5.612e-06 3.482e-05
750 POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 7 28 5.612e-06 3.482e-05
751 ARTERY MORPHOGENESIS 9 51 5.742e-06 3.557e-05
752 POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 8 39 5.902e-06 3.642e-05
753 REGULATION OF GRANULOCYTE CHEMOTAXIS 8 39 5.902e-06 3.642e-05
754 POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 8 39 5.902e-06 3.642e-05
755 REGULATION OF MICROTUBULE BASED PROCESS 20 243 5.973e-06 3.681e-05
756 DETECTION OF OTHER ORGANISM 6 19 6.037e-06 3.711e-05
757 REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 6 19 6.037e-06 3.711e-05
758 HEPATICOBILIARY SYSTEM DEVELOPMENT 14 128 6.121e-06 3.757e-05
759 REGULATION OF RESPONSE TO OXIDATIVE STRESS 10 65 6.316e-06 3.872e-05
760 ACTIVATION OF MAPKK ACTIVITY 9 52 6.785e-06 4.154e-05
761 CELL JUNCTION ORGANIZATION 17 185 6.98e-06 4.268e-05
762 REGULATION OF EPITHELIAL CELL MIGRATION 16 166 7.052e-06 4.306e-05
763 NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 12 96 7.092e-06 4.325e-05
764 MAMMARY GLAND MORPHOGENESIS 8 40 7.211e-06 4.392e-05
765 REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 7 29 7.233e-06 4.4e-05
766 MESODERM MORPHOGENESIS 10 66 7.273e-06 4.412e-05
767 REGULATION OF VASOCONSTRICTION 10 66 7.273e-06 4.412e-05
768 ACTIN FILAMENT BASED PROCESS 29 450 7.372e-06 4.464e-05
769 RESPONSE TO TEMPERATURE STIMULUS 15 148 7.378e-06 4.464e-05
770 OVULATION CYCLE 13 113 7.507e-06 4.536e-05
771 METANEPHROS DEVELOPMENT 11 81 7.599e-06 4.586e-05
772 POSITIVE REGULATION OF CELL CYCLE PROCESS 20 247 7.625e-06 4.596e-05
773 REGULATION OF ACTIN FILAMENT BASED PROCESS 23 312 7.714e-06 4.643e-05
774 REGULATION OF INTERFERON GAMMA PRODUCTION 12 97 7.905e-06 4.752e-05
775 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 9 53 7.987e-06 4.783e-05
776 MAMMARY GLAND EPITHELIUM DEVELOPMENT 9 53 7.987e-06 4.783e-05
777 MESONEPHRIC TUBULE MORPHOGENESIS 9 53 7.987e-06 4.783e-05
778 NEGATIVE REGULATION OF BINDING 14 131 8.025e-06 4.8e-05
779 REGULATION OF AXONOGENESIS 16 168 8.22e-06 4.91e-05
780 RECEPTOR METABOLIC PROCESS 11 82 8.574e-06 5.108e-05
781 INTEGRIN MEDIATED SIGNALING PATHWAY 11 82 8.574e-06 5.108e-05
782 B CELL ACTIVATION 14 132 8.768e-06 5.217e-05
783 NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 7 30 9.225e-06 5.461e-05
784 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 7 30 9.225e-06 5.461e-05
785 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 7 30 9.225e-06 5.461e-05
786 OSTEOCLAST DIFFERENTIATION 7 30 9.225e-06 5.461e-05
787 LEUKOCYTE MEDIATED IMMUNITY 17 189 9.282e-06 5.486e-05
788 SINGLE ORGANISM CELLULAR LOCALIZATION 46 898 9.291e-06 5.486e-05
789 REGULATION OF CELL DIVISION 21 272 9.47e-06 5.578e-05
790 MULTICELLULAR ORGANISMAL HOMEOSTASIS 21 272 9.47e-06 5.578e-05
791 REGULATION OF LIPASE ACTIVITY 11 83 9.656e-06 5.68e-05
792 LIPID MODIFICATION 18 210 9.954e-06 5.848e-05
793 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 13 116 1.002e-05 5.875e-05
794 RESPONSE TO FIBROBLAST GROWTH FACTOR 13 116 1.002e-05 5.875e-05
795 REGULATION OF BLOOD CIRCULATION 22 295 1.011e-05 5.917e-05
796 INTRINSIC APOPTOTIC SIGNALING PATHWAY 15 152 1.021e-05 5.97e-05
797 MITOTIC CELL CYCLE 41 766 1.041e-05 6.078e-05
798 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 8 42 1.057e-05 6.158e-05
799 NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 8 42 1.057e-05 6.158e-05
800 TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 15 153 1.106e-05 6.432e-05
801 REGULATION OF CELL SIZE 16 172 1.109e-05 6.44e-05
802 PROTEIN AUTOPHOSPHORYLATION 17 192 1.143e-05 6.631e-05
803 B CELL HOMEOSTASIS 6 21 1.155e-05 6.694e-05
804 REGULATION OF CELL SUBSTRATE ADHESION 16 173 1.193e-05 6.904e-05
805 POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 11 85 1.218e-05 7.041e-05
806 CARDIOBLAST DIFFERENTIATION 5 13 1.25e-05 7.2e-05
807 ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 13 1.25e-05 7.2e-05
808 NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 13 1.25e-05 7.2e-05
809 DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 8 43 1.27e-05 7.304e-05
810 MACROMOLECULAR COMPLEX ASSEMBLY 63 1398 1.277e-05 7.336e-05
811 REGULATION OF PEPTIDE TRANSPORT 20 256 1.294e-05 7.416e-05
812 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 25 368 1.293e-05 7.416e-05
813 CHROMATIN MODIFICATION 32 539 1.34e-05 7.667e-05
814 RESPONSE TO ALKALOID 14 137 1.347e-05 7.699e-05
815 REGULATION OF PROTEIN CATABOLIC PROCESS 26 393 1.385e-05 7.91e-05
816 ENDODERM DEVELOPMENT 10 71 1.418e-05 8.083e-05
817 ENDOCARDIAL CUSHION DEVELOPMENT 7 32 1.458e-05 8.274e-05
818 PATTERNING OF BLOOD VESSELS 7 32 1.458e-05 8.274e-05
819 NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 7 32 1.458e-05 8.274e-05
820 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 7 32 1.458e-05 8.274e-05
821 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 18 216 1.463e-05 8.294e-05
822 REGULATION OF CIRCADIAN RHYTHM 12 103 1.473e-05 8.339e-05
823 POSITIVE REGULATION OF MUSCLE CONTRACTION 8 44 1.517e-05 8.567e-05
824 NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 8 44 1.517e-05 8.567e-05
825 NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 6 22 1.554e-05 8.72e-05
826 REGULATION OF HAIR CYCLE 6 22 1.554e-05 8.72e-05
827 REGULATION OF INTERLEUKIN 17 PRODUCTION 6 22 1.554e-05 8.72e-05
828 REGULATION OF CELLULAR RESPIRATION 6 22 1.554e-05 8.72e-05
829 CELLULAR RESPONSE TO INTERLEUKIN 6 6 22 1.554e-05 8.72e-05
830 ENDOTHELIAL CELL DIFFERENTIATION 10 72 1.609e-05 9.007e-05
831 DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 10 72 1.609e-05 9.007e-05
832 POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 9 58 1.711e-05 9.568e-05
833 DENDRITIC CELL DIFFERENTIATION 7 33 1.81e-05 0.0001006
834 RESPONSE TO VITAMIN D 7 33 1.81e-05 0.0001006
835 NEGATIVE REGULATION OF JNK CASCADE 7 33 1.81e-05 0.0001006
836 RESPONSE TO DEXAMETHASONE 7 33 1.81e-05 0.0001006
837 REGULATION OF CELL AGING 7 33 1.81e-05 0.0001006
838 NEGATIVE REGULATION OF MAP KINASE ACTIVITY 10 73 1.821e-05 0.0001011
839 REGULATION OF PODOSOME ASSEMBLY 5 14 1.903e-05 0.0001052
840 CRANIOFACIAL SUTURE MORPHOGENESIS 5 14 1.903e-05 0.0001052
841 REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 14 1.903e-05 0.0001052
842 POST EMBRYONIC ORGAN DEVELOPMENT 5 14 1.903e-05 0.0001052
843 ANATOMICAL STRUCTURE HOMEOSTASIS 21 285 1.919e-05 0.0001059
844 CHROMOSOME ORGANIZATION 49 1009 1.937e-05 0.0001068
845 EPIDERMAL CELL DIFFERENTIATION 14 142 2.027e-05 0.0001116
846 REGULATION OF NUCLEASE ACTIVITY 6 23 2.056e-05 0.0001124
847 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 6 23 2.056e-05 0.0001124
848 REGULATION OF ACUTE INFLAMMATORY RESPONSE 10 74 2.058e-05 0.0001124
849 REGULATION OF METANEPHROS DEVELOPMENT 6 23 2.056e-05 0.0001124
850 REGULATION OF STEROID METABOLIC PROCESS 10 74 2.058e-05 0.0001124
851 POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 6 23 2.056e-05 0.0001124
852 NEUROTROPHIN SIGNALING PATHWAY 6 23 2.056e-05 0.0001124
853 ENDOTHELIUM DEVELOPMENT 11 90 2.114e-05 0.0001153
854 REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH 8 46 2.134e-05 0.0001162
855 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 8 46 2.134e-05 0.0001162
856 RESPONSE TO FLUID SHEAR STRESS 7 34 2.228e-05 0.0001204
857 T CELL HOMEOSTASIS 7 34 2.228e-05 0.0001204
858 DNA TEMPLATED TRANSCRIPTION INITIATION 17 202 2.217e-05 0.0001204
859 LIPID METABOLIC PROCESS 54 1158 2.218e-05 0.0001204
860 HEART VALVE DEVELOPMENT 7 34 2.228e-05 0.0001204
861 CELLULAR RESPONSE TO ALKALOID 7 34 2.228e-05 0.0001204
862 SEX DIFFERENTIATION 20 266 2.258e-05 0.0001219
863 REGULATION OF MONOOXYGENASE ACTIVITY 9 60 2.268e-05 0.0001223
864 MONOCARBOXYLIC ACID METABOLIC PROCESS 30 503 2.284e-05 0.000123
865 GRANULOCYTE MIGRATION 10 75 2.32e-05 0.0001246
866 CELLULAR GLUCOSE HOMEOSTASIS 10 75 2.32e-05 0.0001246
867 CARDIAC CHAMBER DEVELOPMENT 14 144 2.374e-05 0.0001274
868 NEGATIVE REGULATION OF PROTEIN SECRETION 12 108 2.39e-05 0.000128
869 REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 12 108 2.39e-05 0.000128
870 REGULATION OF IMMUNOGLOBULIN PRODUCTION 8 47 2.514e-05 0.0001345
871 CELL SUBSTRATE ADHESION 15 164 2.536e-05 0.0001355
872 POSITIVE REGULATION OF STEM CELL PROLIFERATION 9 61 2.601e-05 0.0001388
873 POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 24 2.682e-05 0.000142
874 POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 6 24 2.682e-05 0.000142
875 POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 6 24 2.682e-05 0.000142
876 NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 6 24 2.682e-05 0.000142
877 REGULATION OF ISOTYPE SWITCHING 6 24 2.682e-05 0.000142
878 REGULATION OF ANOIKIS 6 24 2.682e-05 0.000142
879 NEGATIVE REGULATION OF ION TRANSPORT 13 127 2.675e-05 0.000142
880 POSITIVE REGULATION OF VASOCONSTRICTION 7 35 2.723e-05 0.0001438
881 BONE REMODELING 7 35 2.723e-05 0.0001438
882 POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 5 15 2.794e-05 0.0001463
883 REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 15 2.794e-05 0.0001463
884 NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 5 15 2.794e-05 0.0001463
885 NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 5 15 2.794e-05 0.0001463
886 CHRONIC INFLAMMATORY RESPONSE 5 15 2.794e-05 0.0001463
887 POSITIVE REGULATION OF NUCLEASE ACTIVITY 5 15 2.794e-05 0.0001463
888 POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 5 15 2.794e-05 0.0001463
889 T CELL APOPTOTIC PROCESS 5 15 2.794e-05 0.0001463
890 REGULATION OF MYOBLAST DIFFERENTIATION 8 48 2.949e-05 0.000154
891 POSITIVE REGULATION OF WOUND HEALING 8 48 2.949e-05 0.000154
892 FOREBRAIN CELL MIGRATION 9 62 2.973e-05 0.0001549
893 CARDIAC VENTRICLE MORPHOGENESIS 9 62 2.973e-05 0.0001549
894 REGULATION OF VESICLE MEDIATED TRANSPORT 28 462 3.215e-05 0.0001673
895 COGNITION 19 251 3.282e-05 0.0001706
896 POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 7 36 3.306e-05 0.0001715
897 DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE 7 36 3.306e-05 0.0001715
898 REGULATION OF OSTEOCLAST DIFFERENTIATION 9 63 3.39e-05 0.0001755
899 RESPONSE TO OSMOTIC STRESS 9 63 3.39e-05 0.0001755
900 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 17 209 3.43e-05 0.0001773
901 REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 8 49 3.446e-05 0.0001779
902 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 6 25 3.451e-05 0.000178
903 RECEPTOR MEDIATED ENDOCYTOSIS 18 231 3.598e-05 0.0001854
904 NEGATIVE REGULATION OF PROTEIN BINDING 10 79 3.675e-05 0.0001892
905 REGULATION OF CELL CYCLE PHASE TRANSITION 22 321 3.715e-05 0.000191
906 PHAGOCYTOSIS 16 190 3.813e-05 0.0001958
907 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 17 211 3.87e-05 0.0001985
908 SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 11 96 3.897e-05 0.0001997
909 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 5 16 3.978e-05 0.000203
910 REGULATION OF MONONUCLEAR CELL MIGRATION 5 16 3.978e-05 0.000203
911 APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 16 3.978e-05 0.000203
912 REGULATION OF INTERLEUKIN 6 BIOSYNTHETIC PROCESS 5 16 3.978e-05 0.000203
913 NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 37 3.987e-05 0.0002032
914 CELLULAR RESPONSE TO CAMP 8 50 4.01e-05 0.0002041
915 CELL CYCLE PHASE TRANSITION 19 255 4.074e-05 0.0002072
916 IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 22 323 4.079e-05 0.0002072
917 FATTY ACID BIOSYNTHETIC PROCESS 12 114 4.113e-05 0.0002087
918 REGULATION OF CELLULAR SENESCENCE 6 26 4.389e-05 0.0002217
919 NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 26 4.389e-05 0.0002217
920 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 6 26 4.389e-05 0.0002217
921 RESPONSE TO INTERLEUKIN 6 6 26 4.389e-05 0.0002217
922 MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 15 172 4.425e-05 0.0002233
923 REGULATION OF JUN KINASE ACTIVITY 10 81 4.575e-05 0.0002306
924 POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 8 51 4.649e-05 0.0002341
925 RESPONSE TO LIGHT STIMULUS 20 280 4.679e-05 0.0002354
926 MYELOID LEUKOCYTE ACTIVATION 11 98 4.726e-05 0.0002375
927 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 7 38 4.778e-05 0.0002396
928 MESENCHYME MORPHOGENESIS 7 38 4.778e-05 0.0002396
929 CELL CYCLE CHECKPOINT 16 194 4.907e-05 0.0002458
930 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 9 66 4.949e-05 0.0002471
931 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 9 66 4.949e-05 0.0002471
932 POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 9 66 4.949e-05 0.0002471
933 REGULATION OF PROTEIN MATURATION 10 82 5.092e-05 0.0002539
934 MUSCLE SYSTEM PROCESS 20 282 5.169e-05 0.0002575
935 REGULATION OF TRANSMEMBRANE TRANSPORT 26 426 5.451e-05 0.0002713
936 SKELETAL MUSCLE TISSUE REGENERATION 6 27 5.52e-05 0.000273
937 POSITIVE REGULATION OF HEART GROWTH 6 27 5.52e-05 0.000273
938 NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 17 5.515e-05 0.000273
939 MEMBRANE RAFT ORGANIZATION 5 17 5.515e-05 0.000273
940 REGULATION OF RECEPTOR BINDING 5 17 5.515e-05 0.000273
941 AXIS ELONGATION 6 27 5.52e-05 0.000273
942 NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 11 100 5.702e-05 0.0002808
943 PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 7 39 5.694e-05 0.0002808
944 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 11 100 5.702e-05 0.0002808
945 PLATELET AGGREGATION 7 39 5.694e-05 0.0002808
946 REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 14 156 5.778e-05 0.0002839
947 PROTEIN LOCALIZATION TO NUCLEUS 14 156 5.778e-05 0.0002839
948 MESODERM DEVELOPMENT 12 118 5.786e-05 0.000284
949 CHROMATIN ORGANIZATION 35 663 6.147e-05 0.0003014
950 NEGATIVE REGULATION OF LOCOMOTION 19 263 6.185e-05 0.0003026
951 POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 8 53 6.183e-05 0.0003026
952 CELLULAR LIPID METABOLIC PROCESS 44 913 6.232e-05 0.0003046
953 CAMERA TYPE EYE MORPHOGENESIS 11 101 6.252e-05 0.0003052
954 REGULATION OF CELL JUNCTION ASSEMBLY 9 68 6.293e-05 0.0003063
955 REGULATION OF NEUROLOGICAL SYSTEM PROCESS 9 68 6.293e-05 0.0003063
956 POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 9 68 6.293e-05 0.0003063
957 CELL CYCLE G2 M PHASE TRANSITION 13 138 6.409e-05 0.0003116
958 RESPONSE TO CADMIUM ION 7 40 6.749e-05 0.0003278
959 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 6 28 6.873e-05 0.0003321
960 POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 6 28 6.873e-05 0.0003321
961 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 6 28 6.873e-05 0.0003321
962 NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS 6 28 6.873e-05 0.0003321
963 MAMMARY GLAND DUCT MORPHOGENESIS 6 28 6.873e-05 0.0003321
964 MITOTIC CELL CYCLE CHECKPOINT 13 139 6.906e-05 0.000333
965 REGULATION OF CELL SHAPE 13 139 6.906e-05 0.000333
966 PALATE DEVELOPMENT 10 85 6.949e-05 0.0003347
967 NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 9 69 7.073e-05 0.00034
968 POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 9 69 7.073e-05 0.00034
969 REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 8 54 7.096e-05 0.0003407
970 NEGATIVE REGULATION OF IMMUNE RESPONSE 12 121 7.399e-05 0.0003549
971 NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 5 18 7.474e-05 0.0003563
972 SMOOTH MUSCLE TISSUE DEVELOPMENT 5 18 7.474e-05 0.0003563
973 PHARYNGEAL SYSTEM DEVELOPMENT 5 18 7.474e-05 0.0003563
974 LYMPHOCYTE APOPTOTIC PROCESS 5 18 7.474e-05 0.0003563
975 MUSCLE CELL MIGRATION 5 18 7.474e-05 0.0003563
976 RESPONSE TO WATER 5 18 7.474e-05 0.0003563
977 VIRAL LIFE CYCLE 20 290 7.619e-05 0.0003629
978 REGULATION OF CELLULAR COMPONENT SIZE 22 337 7.653e-05 0.0003641
979 POSITIVE REGULATION OF B CELL ACTIVATION 10 86 7.683e-05 0.0003652
980 I KAPPAB KINASE NF KAPPAB SIGNALING 9 70 7.933e-05 0.0003767
981 NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR PROTEIN SIGNALING PATHWAY 7 41 7.959e-05 0.0003767
982 REGULATION OF B CELL MEDIATED IMMUNITY 7 41 7.959e-05 0.0003767
983 PROSTATE GLAND DEVELOPMENT 7 41 7.959e-05 0.0003767
984 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 12 122 8.017e-05 0.0003791
985 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 8 55 8.118e-05 0.0003831
986 REGULATION OF MYOTUBE DIFFERENTIATION 8 55 8.118e-05 0.0003831
987 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 11 104 8.182e-05 0.0003857
988 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 16 203 8.43e-05 0.000397
989 NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 6 29 8.477e-05 0.0003984
990 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 6 29 8.477e-05 0.0003984
991 REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 162 8.706e-05 0.0004087
992 SEXUAL REPRODUCTION 37 730 8.815e-05 0.0004135
993 CATABOLIC PROCESS 72 1773 9.083e-05 0.0004256
994 RAS PROTEIN SIGNAL TRANSDUCTION 13 143 9.245e-05 0.0004327
995 RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 14 163 9.302e-05 0.000435
996 REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 7 42 9.339e-05 0.0004359
997 EPITHELIAL CELL MORPHOGENESIS 7 42 9.339e-05 0.0004359
998 NEGATIVE REGULATION OF HOMEOSTATIC PROCESS 12 124 9.387e-05 0.0004376
999 INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 11 106 9.735e-05 0.0004534
1000 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 5 19 9.928e-05 0.0004587
1001 FIBRIL ORGANIZATION 5 19 9.928e-05 0.0004587
1002 REGULATION OF WATER LOSS VIA SKIN 5 19 9.928e-05 0.0004587
1003 MUSCLE CELL PROLIFERATION 5 19 9.928e-05 0.0004587
1004 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 5 19 9.928e-05 0.0004587
1005 REGULATION OF INTERLEUKIN 8 SECRETION 5 19 9.928e-05 0.0004587
1006 MACROPHAGE DIFFERENTIATION 5 19 9.928e-05 0.0004587
1007 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 19 9.928e-05 0.0004587
1008 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 10 89 0.000103 0.0004753
1009 SMOOTH MUSCLE CELL DIFFERENTIATION 6 30 0.0001037 0.000478
1010 PATTERN SPECIFICATION PROCESS 25 418 0.0001041 0.0004796
1011 SYNAPSE ORGANIZATION 13 145 0.0001065 0.0004902
1012 COVALENT CHROMATIN MODIFICATION 22 345 0.0001077 0.000495
1013 CELL FATE DETERMINATION 7 43 0.0001091 0.0005005
1014 REGULATION OF MULTI ORGANISM PROCESS 27 470 0.000109 0.0005005
1015 RESPONSE TO UV 12 126 0.0001095 0.0005021
1016 POSITIVE REGULATION OF PROTEIN BINDING 9 73 0.0001106 0.0005058
1017 PANCREAS DEVELOPMENT 9 73 0.0001106 0.0005058
1018 CALCIUM MEDIATED SIGNALING 10 90 0.0001132 0.0005163
1019 REGULATION OF CELL MATRIX ADHESION 10 90 0.0001132 0.0005163
1020 REGULATION OF GLIOGENESIS 10 90 0.0001132 0.0005163
1021 CELLULAR RESPONSE TO INSULIN STIMULUS 13 146 0.0001142 0.0005195
1022 NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION 13 146 0.0001142 0.0005195
1023 DNA INTEGRITY CHECKPOINT 13 146 0.0001142 0.0005195
1024 CELLULAR MACROMOLECULE LOCALIZATION 54 1234 0.0001191 0.0005411
1025 REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 13 147 0.0001224 0.0005556
1026 CELL PART MORPHOGENESIS 33 633 0.0001258 0.0005677
1027 RESPONSE TO INTERLEUKIN 4 6 31 0.0001257 0.0005677
1028 NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 11 109 0.0001253 0.0005677
1029 REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 6 31 0.0001257 0.0005677
1030 REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 6 31 0.0001257 0.0005677
1031 UNSATURATED FATTY ACID METABOLIC PROCESS 11 109 0.0001253 0.0005677
1032 POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 11 0.0001279 0.0005719
1033 NEGATIVE REGULATION OF HEMOPOIESIS 12 128 0.0001274 0.0005719
1034 CARDIAC CELL FATE COMMITMENT 4 11 0.0001279 0.0005719
1035 REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 7 44 0.0001268 0.0005719
1036 DETECTION OF MOLECULE OF BACTERIAL ORIGIN 4 11 0.0001279 0.0005719
1037 POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 4 11 0.0001279 0.0005719
1038 MUSCLE CELL DEVELOPMENT 12 128 0.0001274 0.0005719
1039 LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 4 11 0.0001279 0.0005719
1040 NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 4 11 0.0001279 0.0005719
1041 REGULATION OF NECROPTOTIC PROCESS 4 11 0.0001279 0.0005719
1042 REGULATION OF CHROMOSOME ORGANIZATION 19 278 0.0001287 0.0005749
1043 RESPONSE TO PROTOZOAN 5 20 0.0001296 0.0005763
1044 RESPONSE TO LIPOPROTEIN PARTICLE 5 20 0.0001296 0.0005763
1045 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 5 20 0.0001296 0.0005763
1046 MYELOID DENDRITIC CELL DIFFERENTIATION 5 20 0.0001296 0.0005763
1047 POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 8 59 0.000135 0.0005995
1048 VASCULOGENESIS 8 59 0.000135 0.0005995
1049 MITOCHONDRIAL MEMBRANE ORGANIZATION 10 92 0.0001362 0.0006043
1050 SMALL MOLECULE METABOLIC PROCESS 71 1767 0.0001408 0.0006239
1051 REGULATION OF HORMONE LEVELS 27 478 0.0001438 0.0006364
1052 THYMOCYTE AGGREGATION 7 45 0.0001469 0.000646
1053 SPROUTING ANGIOGENESIS 7 45 0.0001469 0.000646
1054 REGULATION OF EPIDERMAL CELL DIFFERENTIATION 7 45 0.0001469 0.000646
1055 T CELL DIFFERENTIATION IN THYMUS 7 45 0.0001469 0.000646
1056 HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 7 45 0.0001469 0.000646
1057 NEGATIVE REGULATION OF CHROMATIN MODIFICATION 7 45 0.0001469 0.000646
1058 ENDOCHONDRAL BONE MORPHOGENESIS 7 45 0.0001469 0.000646
1059 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 10 93 0.0001492 0.0006554
1060 REGULATION OF CALCIUM MEDIATED SIGNALING 9 76 0.0001515 0.0006637
1061 GLIAL CELL DEVELOPMENT 9 76 0.0001515 0.0006637
1062 POSITIVE REGULATION OF DENDRITE MORPHOGENESIS 6 32 0.0001514 0.0006637
1063 OLIGODENDROCYTE DIFFERENTIATION 8 60 0.0001523 0.0006667
1064 TISSUE HOMEOSTASIS 14 171 0.0001549 0.0006775
1065 REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 22 354 0.0001557 0.0006803
1066 PROTEIN LOCALIZATION 72 1805 0.0001568 0.0006843
1067 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 12 131 0.0001588 0.0006926
1068 ORGANIC ACID METABOLIC PROCESS 44 953 0.0001638 0.0007138
1069 CELL AGGREGATION 5 21 0.0001664 0.0007231
1070 APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 5 21 0.0001664 0.0007231
1071 CARTILAGE CONDENSATION 5 21 0.0001664 0.0007231
1072 PEPTIDYL THREONINE MODIFICATION 7 46 0.0001694 0.0007354
1073 REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 8 61 0.0001714 0.0007417
1074 REGULATION OF CHROMATIN ORGANIZATION 13 152 0.0001713 0.0007417
1075 POSITIVE REGULATION OF WNT SIGNALING PATHWAY 13 152 0.0001713 0.0007417
1076 REGULATION OF HORMONE SECRETION 18 262 0.0001802 0.0007794
1077 POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 6 33 0.000181 0.0007798
1078 SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 6 33 0.000181 0.0007798
1079 EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 6 33 0.000181 0.0007798
1080 REGULATION OF INTERLEUKIN 1 SECRETION 6 33 0.000181 0.0007798
1081 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 12 133 0.0001833 0.0007881
1082 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 12 133 0.0001833 0.0007881
1083 LYMPHOCYTE COSTIMULATION 9 78 0.0001852 0.0007958
1084 CELL DIVISION 26 460 0.0001881 0.0008008
1085 SECRETION BY CELL 27 486 0.000188 0.0008008
1086 POSITIVE REGULATION OF CELLULAR EXTRAVASATION 4 12 0.000188 0.0008008
1087 REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 4 12 0.000188 0.0008008
1088 NOTCH SIGNALING PATHWAY 11 114 0.0001871 0.0008008
1089 POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 4 12 0.000188 0.0008008
1090 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS 4 12 0.000188 0.0008008
1091 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 4 12 0.000188 0.0008008
1092 NEGATIVE REGULATION OF RECEPTOR BINDING 4 12 0.000188 0.0008008
1093 POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 4 12 0.000188 0.0008008
1094 REGULATION OF TISSUE REMODELING 8 62 0.0001924 0.0008181
1095 REGULATION OF MITOCHONDRION ORGANIZATION 16 218 0.000193 0.0008201
1096 REACTIVE OXYGEN SPECIES METABOLIC PROCESS 10 96 0.0001943 0.000825
1097 POSITIVE REGULATION OF GLIOGENESIS 7 47 0.0001947 0.0008257
1098 PEPTIDYL LYSINE MODIFICATION 20 312 0.0002042 0.0008651
1099 ERBB SIGNALING PATHWAY 9 79 0.0002043 0.0008651
1100 ENDOCARDIAL CUSHION MORPHOGENESIS 5 22 0.0002108 0.000891
1101 POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT 5 22 0.0002108 0.000891
1102 REGULATION OF CELL KILLING 8 63 0.0002154 0.0009095
1103 RESPONSE TO AMINE 7 48 0.0002229 0.0009385
1104 REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 7 48 0.0002229 0.0009385
1105 REGULATION OF INTERLEUKIN 2 PRODUCTION 7 48 0.0002229 0.0009385
1106 NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 9 80 0.000225 0.0009467
1107 HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 10 98 0.0002304 0.0009685
1108 REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 14 178 0.0002356 0.0009893
1109 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 8 64 0.0002407 0.001009
1110 POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 8 64 0.0002407 0.001009
1111 CELLULAR RESPONSE TO RADIATION 12 137 0.0002419 0.001013
1112 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 10 99 0.0002505 0.001047
1113 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 10 99 0.0002505 0.001047
1114 HORMONE MEDIATED SIGNALING PATHWAY 13 158 0.0002513 0.00105
1115 ACTIN FILAMENT BUNDLE ORGANIZATION 7 49 0.0002543 0.001054
1116 NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 6 35 0.0002539 0.001054
1117 NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION 6 35 0.0002539 0.001054
1118 POSITIVE REGULATION OF HEART CONTRACTION 6 35 0.0002539 0.001054
1119 CARDIAC SEPTUM MORPHOGENESIS 7 49 0.0002543 0.001054
1120 NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 6 35 0.0002539 0.001054
1121 RESPONSE TO IRON ION 6 35 0.0002539 0.001054
1122 CARDIAC CELL DEVELOPMENT 7 49 0.0002543 0.001054
1123 B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 6 35 0.0002539 0.001054
1124 MAINTENANCE OF LOCATION 12 138 0.0002589 0.001072
1125 CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 4 13 0.000266 0.001083
1126 PROSTATE GLAND MORPHOGENESIS 5 23 0.0002637 0.001083
1127 WHITE FAT CELL DIFFERENTIATION 4 13 0.000266 0.001083
1128 POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 5 23 0.0002637 0.001083
1129 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 4 13 0.000266 0.001083
1130 REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 4 13 0.000266 0.001083
1131 POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS 4 13 0.000266 0.001083
1132 EYELID DEVELOPMENT IN CAMERA TYPE EYE 4 13 0.000266 0.001083
1133 REGULATION OF CAMP MEDIATED SIGNALING 5 23 0.0002637 0.001083
1134 REGULATION OF REGULATORY T CELL DIFFERENTIATION 4 13 0.000266 0.001083
1135 RESPONSE TO AUDITORY STIMULUS 5 23 0.0002637 0.001083
1136 POSITIVE REGULATION OF NEUROLOGICAL SYSTEM PROCESS 5 23 0.0002637 0.001083
1137 RESPONSE TO PARATHYROID HORMONE 4 13 0.000266 0.001083
1138 NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 4 13 0.000266 0.001083
1139 RESPONSE TO COBALT ION 4 13 0.000266 0.001083
1140 REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 4 13 0.000266 0.001083
1141 VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 4 13 0.000266 0.001083
1142 POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 13 0.000266 0.001083
1143 REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 4 13 0.000266 0.001083
1144 METENCEPHALON DEVELOPMENT 10 100 0.000272 0.001104
1145 MITOTIC DNA INTEGRITY CHECKPOINT 10 100 0.000272 0.001104
1146 NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION 9 82 0.0002717 0.001104
1147 CELL MATRIX ADHESION 11 119 0.0002731 0.001108
1148 SECOND MESSENGER MEDIATED SIGNALING 13 160 0.0002843 0.001152
1149 POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 7 50 0.0002891 0.001171
1150 REGULATION OF DENDRITE DEVELOPMENT 11 120 0.0002937 0.001188
1151 KERATINOCYTE DIFFERENTIATION 10 101 0.000295 0.001191
1152 REGULATION OF EXTENT OF CELL GROWTH 10 101 0.000295 0.001191
1153 NEUROMUSCULAR JUNCTION DEVELOPMENT 6 36 0.000298 0.001199
1154 NEGATIVE REGULATION OF HISTONE MODIFICATION 6 36 0.000298 0.001199
1155 NEGATIVE REGULATION OF BLOOD CIRCULATION 6 36 0.000298 0.001199
1156 NIK NF KAPPAB SIGNALING 9 83 0.0002978 0.001199
1157 CELLULAR RESPONSE TO HEAT 6 36 0.000298 0.001199
1158 REGULATION OF MULTICELLULAR ORGANISM GROWTH 8 66 0.0002985 0.001199
1159 POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 25 448 0.0003014 0.00121
1160 REGULATION OF SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM 15 205 0.0003133 0.001257
1161 NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 10 102 0.0003196 0.001281
1162 NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 5 24 0.000326 0.001303
1163 POSITIVE REGULATION OF INTERLEUKIN 1 SECRETION 5 24 0.000326 0.001303
1164 REGULATION OF ODONTOGENESIS 5 24 0.000326 0.001303
1165 RESPONSE TO AMMONIUM ION 7 51 0.0003277 0.001305
1166 POSITIVE REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 7 51 0.0003277 0.001305
1167 CELLULAR RESPONSE TO FATTY ACID 7 51 0.0003277 0.001305
1168 HOMOTYPIC CELL CELL ADHESION 7 51 0.0003277 0.001305
1169 POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 7 51 0.0003277 0.001305
1170 NEURON FATE COMMITMENT 8 67 0.0003314 0.001317
1171 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 14 184 0.0003312 0.001317
1172 LOCALIZATION WITHIN MEMBRANE 11 122 0.000339 0.001346
1173 RESPONSE TO NERVE GROWTH FACTOR 6 37 0.000348 0.001377
1174 POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 6 37 0.000348 0.001377
1175 REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 6 37 0.000348 0.001377
1176 POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 37 0.000348 0.001377
1177 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 4 14 0.0003648 0.001432
1178 LAYER FORMATION IN CEREBRAL CORTEX 4 14 0.0003648 0.001432
1179 NEGATIVE REGULATION OF JUN KINASE ACTIVITY 4 14 0.0003648 0.001432
1180 ATRIAL SEPTUM MORPHOGENESIS 4 14 0.0003648 0.001432
1181 POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 4 14 0.0003648 0.001432
1182 RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE 4 14 0.0003648 0.001432
1183 METANEPHRIC MESENCHYME DEVELOPMENT 4 14 0.0003648 0.001432
1184 POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 4 14 0.0003648 0.001432
1185 REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 4 14 0.0003648 0.001432
1186 REGULATION OF ALPHA BETA T CELL ACTIVATION 8 68 0.0003672 0.001439
1187 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 8 68 0.0003672 0.001439
1188 NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 7 52 0.0003704 0.001446
1189 NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS 7 52 0.0003704 0.001446
1190 NEGATIVE REGULATION OF T CELL PROLIFERATION 7 52 0.0003704 0.001446
1191 POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 7 52 0.0003704 0.001446
1192 RESPONSE TO FUNGUS 7 52 0.0003704 0.001446
1193 NEGATIVE REGULATION OF DEFENSE RESPONSE 12 144 0.0003831 0.001494
1194 LENS FIBER CELL DIFFERENTIATION 5 25 0.0003989 0.001548
1195 MEMBRANE ASSEMBLY 5 25 0.0003989 0.001548
1196 CELLULAR EXTRAVASATION 5 25 0.0003989 0.001548
1197 HISTONE PHOSPHORYLATION 5 25 0.0003989 0.001548
1198 POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 5 25 0.0003989 0.001548
1199 THYROID GLAND DEVELOPMENT 5 25 0.0003989 0.001548
1200 POSITIVE REGULATION OF ORGAN GROWTH 6 38 0.0004043 0.001568
1201 RESPONSE TO ACTIVITY 8 69 0.000406 0.001573
1202 NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 9 87 0.0004242 0.001642
1203 POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION 13 167 0.0004303 0.001664
1204 CARDIAC VENTRICLE DEVELOPMENT 10 106 0.0004359 0.001685
1205 GAMETE GENERATION 30 595 0.0004424 0.001708
1206 REGULATION OF MEMBRANE PERMEABILITY 8 70 0.0004482 0.001729
1207 PROTEIN OLIGOMERIZATION 24 434 0.0004505 0.001737
1208 LYMPHOCYTE MEDIATED IMMUNITY 12 147 0.0004621 0.001779
1209 OVULATION CYCLE PROCESS 9 88 0.0004619 0.001779
1210 REGULATION OF PHOSPHOLIPASE C ACTIVITY 6 39 0.0004674 0.001795
1211 TRABECULA MORPHOGENESIS 6 39 0.0004674 0.001795
1212 CELLULAR RESPONSE TO NUTRIENT 6 39 0.0004674 0.001795
1213 PLATELET DEGRANULATION 10 107 0.00047 0.001803
1214 REGULATION OF BLOOD PRESSURE 13 169 0.0004821 0.001832
1215 REGULATION OF TYPE 2 IMMUNE RESPONSE 5 26 0.0004834 0.001832
1216 POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 5 26 0.0004834 0.001832
1217 REGULATION OF MESONEPHROS DEVELOPMENT 5 26 0.0004834 0.001832
1218 REPLACEMENT OSSIFICATION 5 26 0.0004834 0.001832
1219 CELLULAR RESPONSE TO INTERLEUKIN 4 5 26 0.0004834 0.001832
1220 NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 5 26 0.0004834 0.001832
1221 APPENDAGE DEVELOPMENT 13 169 0.0004821 0.001832
1222 SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 11 127 0.0004787 0.001832
1223 POSITIVE REGULATION OF IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 5 26 0.0004834 0.001832
1224 MESODERMAL CELL DIFFERENTIATION 5 26 0.0004834 0.001832
1225 LIMB DEVELOPMENT 13 169 0.0004821 0.001832
1226 ENDOCHONDRAL OSSIFICATION 5 26 0.0004834 0.001832
1227 CELLULAR RESPONSE TO VITAMIN 5 26 0.0004834 0.001832
1228 MYELOID DENDRITIC CELL ACTIVATION 5 26 0.0004834 0.001832
1229 RESPONSE TO MURAMYL DIPEPTIDE 4 15 0.0004872 0.001836
1230 NEGATIVE REGULATION OF HISTONE ACETYLATION 4 15 0.0004872 0.001836
1231 POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 4 15 0.0004872 0.001836
1232 JAK STAT CASCADE INVOLVED IN GROWTH HORMONE SIGNALING PATHWAY 4 15 0.0004872 0.001836
1233 MUSCLE CELL FATE COMMITMENT 4 15 0.0004872 0.001836
1234 STRIATED MUSCLE CELL PROLIFERATION 4 15 0.0004872 0.001836
1235 RESPONSE TO HYDROPEROXIDE 4 15 0.0004872 0.001836
1236 MALE SEX DIFFERENTIATION 12 148 0.0004913 0.00185
1237 NEGATIVE REGULATION OF CELL CYCLE PROCESS 15 214 0.0004938 0.001858
1238 ORGANOPHOSPHATE METABOLIC PROCESS 40 885 0.0004948 0.00186
1239 POSITIVE REGULATION OF CAMP METABOLIC PROCESS 9 89 0.0005022 0.001886
1240 NEGATIVE REGULATION OF CELL GROWTH 13 170 0.00051 0.001914
1241 REGULATION OF PHOSPHATASE ACTIVITY 11 128 0.0005117 0.001919
1242 NAD METABOLIC PROCESS 7 55 0.0005255 0.001967
1243 NATURAL KILLER CELL ACTIVATION 7 55 0.0005255 0.001967
1244 REGIONALIZATION 19 311 0.0005295 0.001981
1245 PHOSPHATIDYLINOSITOL METABOLIC PROCESS 14 193 0.0005361 0.002004
1246 HINDBRAIN MORPHOGENESIS 6 40 0.000538 0.002008
1247 NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 6 40 0.000538 0.002008
1248 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 13 172 0.0005698 0.002125
1249 NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 27 0.0005807 0.002153
1250 POSITIVE REGULATION OF NEUTROPHIL MIGRATION 5 27 0.0005807 0.002153
1251 POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 27 0.0005807 0.002153
1252 NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 5 27 0.0005807 0.002153
1253 CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 5 27 0.0005807 0.002153
1254 POSITIVE REGULATION OF NF KAPPAB IMPORT INTO NUCLEUS 5 27 0.0005807 0.002153
1255 HETEROTYPIC CELL CELL ADHESION 5 27 0.0005807 0.002153
1256 NEURON MIGRATION 10 110 0.0005855 0.002169
1257 ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 14 195 0.000594 0.002199
1258 HIPPOCAMPUS DEVELOPMENT 8 73 0.0005964 0.002206
1259 REGULATION OF LIPID STORAGE 6 41 0.0006166 0.002273
1260 TRANSLESION SYNTHESIS 6 41 0.0006166 0.002273
1261 CELLULAR RESPONSE TO ESTROGEN STIMULUS 6 41 0.0006166 0.002273
1262 MONOCYTE CHEMOTAXIS 6 41 0.0006166 0.002273
1263 LEARNING 11 131 0.0006224 0.002293
1264 POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL 14 196 0.0006248 0.0023
1265 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 10 111 0.0006288 0.002313
1266 MODULATION OF GROWTH OF SYMBIONT INVOLVED IN INTERACTION WITH HOST 4 16 0.0006364 0.002328
1267 CARDIAC MYOFIBRIL ASSEMBLY 4 16 0.0006364 0.002328
1268 REGULATION OF MACROPHAGE CHEMOTAXIS 4 16 0.0006364 0.002328
1269 ACTIN FILAMENT ORGANIZATION 13 174 0.0006355 0.002328
1270 CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 4 16 0.0006364 0.002328
1271 NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 4 16 0.0006364 0.002328
1272 MONOCYTE DIFFERENTIATION 4 16 0.0006364 0.002328
1273 SINGLE ORGANISM CATABOLIC PROCESS 42 957 0.0006504 0.002377
1274 POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 7 57 0.0006548 0.002388
1275 REGULATION OF DENDRITE MORPHOGENESIS 8 74 0.0006538 0.002388
1276 APOPTOTIC MITOCHONDRIAL CHANGES 7 57 0.0006548 0.002388
1277 POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 5 28 0.000692 0.002506
1278 NECROTIC CELL DEATH 5 28 0.000692 0.002506
1279 CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 5 28 0.000692 0.002506
1280 REGULATION OF NEUROBLAST PROLIFERATION 5 28 0.000692 0.002506
1281 LONG TERM MEMORY 5 28 0.000692 0.002506
1282 T CELL MEDIATED IMMUNITY 5 28 0.000692 0.002506
1283 REGULATION OF SPROUTING ANGIOGENESIS 5 28 0.000692 0.002506
1284 RESPONSE TO GONADOTROPIN 5 28 0.000692 0.002506
1285 POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 5 28 0.000692 0.002506
1286 POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 6 42 0.0007038 0.002544
1287 REGULATION OF NIK NF KAPPAB SIGNALING 6 42 0.0007038 0.002544
1288 REGULATION OF DNA REPAIR 8 75 0.0007156 0.002583
1289 ODONTOGENESIS OF DENTIN CONTAINING TOOTH 8 75 0.0007156 0.002583
1290 REGULATION OF DNA RECOMBINATION 7 58 0.0007283 0.002627
1291 CARBOXYLIC ACID BIOSYNTHETIC PROCESS 17 270 0.0007323 0.002637
1292 ORGANIC ACID BIOSYNTHETIC PROCESS 17 270 0.0007323 0.002637
1293 MORPHOGENESIS OF EMBRYONIC EPITHELIUM 11 134 0.0007524 0.002708
1294 DNA METABOLIC PROCESS 35 758 0.000759 0.002729
1295 REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 10 114 0.0007751 0.002783
1296 FATTY ACID METABOLIC PROCESS 18 296 0.0007756 0.002783
1297 REGULATION OF EMBRYONIC DEVELOPMENT 10 114 0.0007751 0.002783
1298 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 11 135 0.0008004 0.002865
1299 NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 6 43 0.0008002 0.002865
1300 MORPHOGENESIS OF AN EPITHELIAL SHEET 6 43 0.0008002 0.002865
1301 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 4 17 0.0008152 0.002889
1302 BRANCH ELONGATION OF AN EPITHELIUM 4 17 0.0008152 0.002889
1303 POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 17 0.0008152 0.002889
1304 HEXOSE TRANSMEMBRANE TRANSPORT 4 17 0.0008152 0.002889
1305 ANATOMICAL STRUCTURE ARRANGEMENT 4 17 0.0008152 0.002889
1306 REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 7 59 0.0008081 0.002889
1307 NEGATIVE REGULATION OF CELL AGING 4 17 0.0008152 0.002889
1308 REGULATION OF PLATELET AGGREGATION 4 17 0.0008152 0.002889
1309 REGULATION OF TRANSCRIPTION FACTOR IMPORT INTO NUCLEUS 9 95 0.0008098 0.002889
1310 POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 4 17 0.0008152 0.002889
1311 POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 4 17 0.0008152 0.002889
1312 GLUCOSE TRANSMEMBRANE TRANSPORT 4 17 0.0008152 0.002889
1313 REGULATION OF PRI MIRNA TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 4 17 0.0008152 0.002889
1314 STEM CELL DIVISION 5 29 0.0008185 0.002894
1315 POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING 5 29 0.0008185 0.002894
1316 REGULATION OF THE FORCE OF HEART CONTRACTION 5 29 0.0008185 0.002894
1317 NEGATIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 11 136 0.000851 0.003007
1318 REGULATION OF DEPHOSPHORYLATION 12 158 0.0008792 0.003104
1319 FEMALE SEX DIFFERENTIATION 10 116 0.0008873 0.00313
1320 T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 7 60 0.0008948 0.003152
1321 MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 7 60 0.0008948 0.003152
1322 HINDBRAIN DEVELOPMENT 11 137 0.0009042 0.003182
1323 POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 5 30 0.0009615 0.003366
1324 MEMBRANE BIOGENESIS 5 30 0.0009615 0.003366
1325 POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 5 30 0.0009615 0.003366
1326 BLASTOCYST FORMATION 5 30 0.0009615 0.003366
1327 BROWN FAT CELL DIFFERENTIATION 5 30 0.0009615 0.003366
1328 RESPONSE TO ATP 5 30 0.0009615 0.003366
1329 CELLULAR RESPONSE TO ESTRADIOL STIMULUS 5 30 0.0009615 0.003366
1330 NEGATIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 7 61 0.0009885 0.003458
1331 MEMORY 9 98 0.001013 0.003536
1332 TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 10 118 0.001013 0.003536
1333 NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 9 98 0.001013 0.003536
1334 ENDOTHELIAL CELL DEVELOPMENT 6 45 0.001023 0.003564
1335 POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 6 45 0.001023 0.003564
1336 SMOOTH MUSCLE CONTRACTION 6 45 0.001023 0.003564
1337 ATRIAL SEPTUM DEVELOPMENT 4 18 0.001027 0.003566
1338 RESPONSE TO CAFFEINE 4 18 0.001027 0.003566
1339 KIDNEY MESENCHYME DEVELOPMENT 4 18 0.001027 0.003566
1340 POSITIVE REGULATION OF DNA RECOMBINATION 4 18 0.001027 0.003566
1341 GLUCOSE METABOLIC PROCESS 10 119 0.00108 0.003746
1342 POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 10 119 0.00108 0.003746
1343 DNA DEPENDENT DNA REPLICATION 9 99 0.001089 0.00377
1344 BLASTOCYST DEVELOPMENT 7 62 0.00109 0.00377
1345 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 9 99 0.001089 0.00377
1346 DNA REPLICATION 14 208 0.001115 0.003854
1347 CARDIAC ATRIUM DEVELOPMENT 5 31 0.001122 0.003862
1348 REGULATION OF MICROTUBULE POLYMERIZATION 5 31 0.001122 0.003862
1349 NEURON FATE SPECIFICATION 5 31 0.001122 0.003862
1350 POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 5 31 0.001122 0.003862
1351 MISMATCH REPAIR 5 31 0.001122 0.003862
1352 REGULATION OF PLATELET ACTIVATION 5 31 0.001122 0.003862
1353 ICOSANOID BIOSYNTHETIC PROCESS 6 46 0.001152 0.003951
1354 CEREBELLAR CORTEX DEVELOPMENT 6 46 0.001152 0.003951
1355 REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 6 46 0.001152 0.003951
1356 FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 6 46 0.001152 0.003951
1357 ESTABLISHMENT OF LOCALIZATION IN CELL 64 1676 0.001153 0.003952
1358 REGULATION OF PEPTIDE SECRETION 14 209 0.001167 0.003999
1359 NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 7 63 0.001199 0.004106
1360 DEFENSE RESPONSE TO VIRUS 12 164 0.001216 0.00416
1361 MICROTUBULE BASED PROCESS 26 522 0.001242 0.004248
1362 PROSTAGLANDIN BIOSYNTHETIC PROCESS 4 19 0.001274 0.004315
1363 NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 4 19 0.001274 0.004315
1364 THYMIC T CELL SELECTION 4 19 0.001274 0.004315
1365 CELLULAR RESPONSE TO FLUID SHEAR STRESS 4 19 0.001274 0.004315
1366 REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 4 19 0.001274 0.004315
1367 NEGATIVE REGULATION OF NUCLEOSIDE METABOLIC PROCESS 4 19 0.001274 0.004315
1368 NEGATIVE REGULATION OF ATP METABOLIC PROCESS 4 19 0.001274 0.004315
1369 ENTEROENDOCRINE CELL DIFFERENTIATION 4 19 0.001274 0.004315
1370 CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 4 19 0.001274 0.004315
1371 ERROR PRONE TRANSLESION SYNTHESIS 4 19 0.001274 0.004315
1372 MUSCLE CELL CELLULAR HOMEOSTASIS 4 19 0.001274 0.004315
1373 PROSTANOID BIOSYNTHETIC PROCESS 4 19 0.001274 0.004315
1374 ASTROCYTE DEVELOPMENT 4 19 0.001274 0.004315
1375 MITOTIC NUCLEAR DIVISION 20 361 0.001282 0.004338
1376 NEURON DEATH 6 47 0.001292 0.004364
1377 POSITIVE REGULATION OF DEPHOSPHORYLATION 6 47 0.001292 0.004364
1378 MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 5 32 0.001302 0.004384
1379 BLOOD VESSEL REMODELING 5 32 0.001302 0.004384
1380 NEGATIVE REGULATION OF T CELL DIFFERENTIATION 5 32 0.001302 0.004384
1381 REGULATION OF NEUTROPHIL MIGRATION 5 32 0.001302 0.004384
1382 ADIPOSE TISSUE DEVELOPMENT 5 32 0.001302 0.004384
1383 NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 7 64 0.001317 0.004427
1384 REGULATION OF PROTEIN ACETYLATION 7 64 0.001317 0.004427
1385 SMALL MOLECULE BIOSYNTHETIC PROCESS 23 443 0.001366 0.004589
1386 RESPONSE TO FATTY ACID 8 83 0.001397 0.004691
1387 RESPONSE TO AXON INJURY 6 48 0.001444 0.004828
1388 NEGATIVE REGULATION OF COAGULATION 6 48 0.001444 0.004828
1389 REGULATION OF LIPID KINASE ACTIVITY 6 48 0.001444 0.004828
1390 DIGESTIVE TRACT MORPHOGENESIS 6 48 0.001444 0.004828
1391 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 6 48 0.001444 0.004828
1392 PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 7 65 0.001443 0.004828
1393 POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 5 33 0.001502 0.005011
1394 EMBRYONIC EYE MORPHOGENESIS 5 33 0.001502 0.005011
1395 G2 DNA DAMAGE CHECKPOINT 5 33 0.001502 0.005011
1396 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 8 84 0.00151 0.005033
1397 T CELL RECEPTOR SIGNALING PATHWAY 11 146 0.001518 0.005057
1398 CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 4 20 0.00156 0.005156
1399 NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 4 20 0.00156 0.005156
1400 NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 4 20 0.00156 0.005156
1401 ESTABLISHMENT OF MITOTIC SPINDLE ORIENTATION 4 20 0.00156 0.005156
1402 CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 4 20 0.00156 0.005156
1403 TELENCEPHALON GLIAL CELL MIGRATION 4 20 0.00156 0.005156
1404 ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 4 20 0.00156 0.005156
1405 MEGAKARYOCYTE DIFFERENTIATION 4 20 0.00156 0.005156
1406 REGULATION OF TYROSINE PHOSPHORYLATION OF STAT5 PROTEIN 4 20 0.00156 0.005156
1407 BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 4 20 0.00156 0.005156
1408 RESPONSE TO LEAD ION 4 20 0.00156 0.005156
1409 STEROID HORMONE MEDIATED SIGNALING PATHWAY 10 125 0.00157 0.005184
1410 CELLULAR RESPONSE TO UV 7 66 0.001579 0.005208
1411 LENS DEVELOPMENT IN CAMERA TYPE EYE 7 66 0.001579 0.005208
1412 REGULATION OF NUCLEOSIDE METABOLIC PROCESS 6 49 0.00161 0.005303
1413 REGULATION OF ATP METABOLIC PROCESS 6 49 0.00161 0.005303
1414 CARDIAC SEPTUM DEVELOPMENT 8 85 0.00163 0.005363
1415 REGULATION OF PROTEIN COMPLEX DISASSEMBLY 14 217 0.001666 0.005477
1416 PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 34 0.001724 0.005648
1417 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 7 67 0.001725 0.005648
1418 CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 34 0.001724 0.005648
1419 ER NUCLEUS SIGNALING PATHWAY 5 34 0.001724 0.005648
1420 REGULATION OF NOTCH SIGNALING PATHWAY 7 67 0.001725 0.005648
1421 REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 5 34 0.001724 0.005648
1422 FACE DEVELOPMENT 6 50 0.00179 0.005859
1423 METANEPHRIC NEPHRON MORPHOGENESIS 4 21 0.001888 0.006127
1424 NECROPTOTIC PROCESS 4 21 0.001888 0.006127
1425 REGULATION OF PROTEIN IMPORT INTO NUCLEUS TRANSLOCATION 4 21 0.001888 0.006127
1426 CHONDROCYTE DEVELOPMENT 4 21 0.001888 0.006127
1427 DECIDUALIZATION 4 21 0.001888 0.006127
1428 POSITIVE T CELL SELECTION 4 21 0.001888 0.006127
1429 ORGAN GROWTH 7 68 0.001881 0.006127
1430 NERVE DEVELOPMENT 7 68 0.001881 0.006127
1431 VIRAL GENOME REPLICATION 4 21 0.001888 0.006127
1432 REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 4 21 0.001888 0.006127
1433 NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 4 21 0.001888 0.006127
1434 NEGATIVE REGULATION OF PROTEIN ACETYLATION 4 21 0.001888 0.006127
1435 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 8 87 0.001892 0.006135
1436 NADH METABOLIC PROCESS 5 35 0.001969 0.006367
1437 MEMBRANE PROTEIN PROTEOLYSIS 5 35 0.001969 0.006367
1438 RESPONSE TO MONOAMINE 5 35 0.001969 0.006367
1439 REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 5 35 0.001969 0.006367
1440 REGULATION OF HEART CONTRACTION 14 221 0.001975 0.00638
1441 MICROTUBULE CYTOSKELETON ORGANIZATION 19 348 0.00198 0.006387
1442 NEURAL CREST CELL MIGRATION 6 51 0.001985 0.006387
1443 REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 6 51 0.001985 0.006387
1444 NUCLEAR IMPORT 10 129 0.001986 0.006387
1445 CELL JUNCTION ASSEMBLY 10 129 0.001986 0.006387
1446 NEGATIVE REGULATION OF MULTI ORGANISM PROCESS 11 151 0.001986 0.006387
1447 REGULATION OF CAMP METABOLIC PROCESS 10 129 0.001986 0.006387
1448 MALE GAMETE GENERATION 24 486 0.002108 0.006775
1449 POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 9 109 0.002138 0.006866
1450 WNT SIGNALING PATHWAY 19 351 0.00218 0.006996
1451 POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 6 52 0.002196 0.007042
1452 OXIDATION REDUCTION PROCESS 38 898 0.002214 0.007093
1453 MUSCLE ORGAN MORPHOGENESIS 7 70 0.002225 0.007122
1454 RETINA DEVELOPMENT IN CAMERA TYPE EYE 10 131 0.002226 0.007122
1455 CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 5 36 0.002239 0.00714
1456 POSITIVE REGULATION OF AXON EXTENSION 5 36 0.002239 0.00714
1457 TOXIN TRANSPORT 5 36 0.002239 0.00714
1458 NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 5 36 0.002239 0.00714
1459 POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 36 0.002239 0.00714
1460 CELLULAR RESPONSE TO VIRUS 4 22 0.002261 0.007167
1461 NEGATIVE REGULATION OF MUSCLE CONTRACTION 4 22 0.002261 0.007167
1462 BONE CELL DEVELOPMENT 4 22 0.002261 0.007167
1463 SEX DETERMINATION 4 22 0.002261 0.007167
1464 POSITIVE REGULATION OF PROTEIN OLIGOMERIZATION 4 22 0.002261 0.007167
1465 REGULATION OF CELLULAR EXTRAVASATION 4 22 0.002261 0.007167
1466 REGULATION OF T CELL CYTOKINE PRODUCTION 4 22 0.002261 0.007167
1467 EMBRYONIC PLACENTA MORPHOGENESIS 4 22 0.002261 0.007167
1468 HISTONE H3 DEACETYLATION 4 22 0.002261 0.007167
1469 POSITIVE REGULATION OF CELL DIVISION 10 132 0.002354 0.007455
1470 URETER DEVELOPMENT 3 11 0.002454 0.007627
1471 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 6 53 0.002423 0.007627
1472 REGULATION OF CHOLESTEROL HOMEOSTASIS 3 11 0.002454 0.007627
1473 NEGATIVE REGULATION OF SODIUM ION TRANSPORT 3 11 0.002454 0.007627
1474 SENSORY PERCEPTION OF MECHANICAL STIMULUS 11 155 0.002439 0.007627
1475 POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS 9 111 0.002422 0.007627
1476 NEGATIVE REGULATION OF GLYCOLYTIC PROCESS 3 11 0.002454 0.007627
1477 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 3 11 0.002454 0.007627
1478 VENTRAL SPINAL CORD INTERNEURON SPECIFICATION 3 11 0.002454 0.007627
1479 RESPONSE TO GRAVITY 3 11 0.002454 0.007627
1480 REGULATION OF T HELPER 2 CELL DIFFERENTIATION 3 11 0.002454 0.007627
1481 REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS 11 155 0.002439 0.007627
1482 REGULATION OF CHRONIC INFLAMMATORY RESPONSE 3 11 0.002454 0.007627
1483 SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 3 11 0.002454 0.007627
1484 NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 6 53 0.002423 0.007627
1485 REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 3 11 0.002454 0.007627
1486 BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 3 11 0.002454 0.007627
1487 CYCLOOXYGENASE PATHWAY 3 11 0.002454 0.007627
1488 NEGATIVE REGULATION OF CELLULAR SENESCENCE 3 11 0.002454 0.007627
1489 NEGATIVE REGULATION OF COENZYME METABOLIC PROCESS 3 11 0.002454 0.007627
1490 POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 3 11 0.002454 0.007627
1491 NEGATIVE REGULATION OF COFACTOR METABOLIC PROCESS 3 11 0.002454 0.007627
1492 NEGATIVE REGULATION OF DNA METABOLIC PROCESS 9 111 0.002422 0.007627
1493 CELL FATE SPECIFICATION 7 71 0.002414 0.007627
1494 REGULATION OF INTERFERON GAMMA SECRETION 3 11 0.002454 0.007627
1495 CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 3 11 0.002454 0.007627
1496 VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 3 11 0.002454 0.007627
1497 NEGATIVE REGULATION OF NECROTIC CELL DEATH 3 11 0.002454 0.007627
1498 CELLULAR RESPONSE TO LIGHT STIMULUS 8 91 0.002516 0.007814
1499 ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 4 23 0.002682 0.008258
1500 POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 4 23 0.002682 0.008258
1501 POSTREPLICATION REPAIR 6 54 0.002667 0.008258
1502 CRANIAL NERVE MORPHOGENESIS 4 23 0.002682 0.008258
1503 REGULATION OF OSTEOBLAST PROLIFERATION 4 23 0.002682 0.008258
1504 EPIBOLY 4 23 0.002682 0.008258
1505 MONOSACCHARIDE TRANSPORT 6 54 0.002667 0.008258
1506 ACTIN FILAMENT POLYMERIZATION 4 23 0.002682 0.008258
1507 REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 6 54 0.002667 0.008258
1508 TRABECULA FORMATION 4 23 0.002682 0.008258
1509 STRIATED MUSCLE ADAPTATION 4 23 0.002682 0.008258
1510 POSITIVE REGULATION OF STEROID METABOLIC PROCESS 4 23 0.002682 0.008258
1511 REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER 4 23 0.002682 0.008258
1512 HEXOSE METABOLIC PROCESS 11 157 0.002694 0.008292
1513 CELL GROWTH 10 135 0.002774 0.008529
1514 EMBRYONIC HEART TUBE DEVELOPMENT 7 73 0.00283 0.008691
1515 G1 DNA DAMAGE CHECKPOINT 7 73 0.00283 0.008691
1516 REGULATION OF DOUBLE STRAND BREAK REPAIR 5 38 0.002857 0.00874
1517 SPINDLE LOCALIZATION 5 38 0.002857 0.00874
1518 POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 5 38 0.002857 0.00874
1519 REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 5 38 0.002857 0.00874
1520 CYTOKINE SECRETION 5 38 0.002857 0.00874
1521 REGULATION OF LYMPHOCYTE MIGRATION 5 38 0.002857 0.00874
1522 REGULATION OF ENDOTHELIAL CELL MIGRATION 9 114 0.002903 0.008874
1523 FC RECEPTOR SIGNALING PATHWAY 13 206 0.002912 0.008898
1524 ORGANELLE LOCALIZATION 21 415 0.002938 0.008969
1525 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 14 232 0.003077 0.009389
1526 REGULATION OF DNA BIOSYNTHETIC PROCESS 8 94 0.003081 0.009395
1527 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 4 24 0.003153 0.009575
1528 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 4 24 0.003153 0.009575
1529 RESPONSE TO STEROL 4 24 0.003153 0.009575
1530 SPINAL CORD PATTERNING 4 24 0.003153 0.009575
1531 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 4 24 0.003153 0.009575
1532 ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 4 24 0.003153 0.009575
1533 TOLERANCE INDUCTION 3 12 0.003209 0.009591
1534 RESPONSE TO ENDOPLASMIC RETICULUM STRESS 14 233 0.003198 0.009591
1535 REGULATION OF TIMING OF CELL DIFFERENTIATION 3 12 0.003209 0.009591
1536 ATP GENERATION FROM ADP 5 39 0.003208 0.009591
1537 POSITIVE REGULATION OF THYMOCYTE AGGREGATION 3 12 0.003209 0.009591
1538 NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 3 12 0.003209 0.009591
1539 ERBB2 SIGNALING PATHWAY 5 39 0.003208 0.009591
1540 CELLULAR RESPONSE TO ATP 3 12 0.003209 0.009591
1541 NEGATIVE REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS 3 12 0.003209 0.009591
1542 MUSCLE CONTRACTION 14 233 0.003198 0.009591
1543 REGULATION OF CHEMOKINE SECRETION 3 12 0.003209 0.009591
1544 POST EMBRYONIC MORPHOGENESIS 3 12 0.003209 0.009591
1545 EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 5 39 0.003208 0.009591
1546 REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS 3 12 0.003209 0.009591
1547 PERK MEDIATED UNFOLDED PROTEIN RESPONSE 3 12 0.003209 0.009591
1548 I KAPPAB PHOSPHORYLATION 3 12 0.003209 0.009591
1549 COCHLEA DEVELOPMENT 5 39 0.003208 0.009591
1550 REGULATION OF DEVELOPMENT HETEROCHRONIC 3 12 0.003209 0.009591
1551 POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 3 12 0.003209 0.009591
1552 CELL ADHESION MEDIATED BY INTEGRIN 3 12 0.003209 0.009591
1553 RENAL ABSORPTION 3 12 0.003209 0.009591
1554 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 3 12 0.003209 0.009591
1555 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 3 12 0.003209 0.009591
1556 REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 3 12 0.003209 0.009591
1557 SPLEEN DEVELOPMENT 5 39 0.003208 0.009591
1558 PHOSPHOLIPID METABOLIC PROCESS 19 364 0.003257 0.009726
1559 PROTEIN SECRETION 9 116 0.003263 0.009738
1560 NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 8 95 0.00329 0.009806
1561 CANONICAL WNT SIGNALING PATHWAY 8 95 0.00329 0.009806
NumGOOverlapSizeP ValueAdj. P Value
1 RECEPTOR BINDING 130 1476 1.254e-36 1.165e-33
2 MACROMOLECULAR COMPLEX BINDING 115 1399 2.11e-29 9.803e-27
3 ENZYME BINDING 129 1737 7.199e-29 2.229e-26
4 IDENTICAL PROTEIN BINDING 102 1209 7.816e-27 1.815e-24
5 TRANSCRIPTION FACTOR BINDING 63 524 1.436e-24 2.668e-22
6 REGULATORY REGION NUCLEIC ACID BINDING 74 818 3.564e-21 5.519e-19
7 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 64 629 5.137e-21 6.818e-19
8 DOUBLE STRANDED DNA BINDING 65 764 2.639e-17 3.064e-15
9 PROTEIN KINASE ACTIVITY 58 640 9.27e-17 9.569e-15
10 SEQUENCE SPECIFIC DNA BINDING 76 1037 1.814e-16 1.686e-14
11 KINASE ACTIVITY 67 842 2.432e-16 2.054e-14
12 PROTEIN DIMERIZATION ACTIVITY 80 1149 4.817e-16 3.729e-14
13 KINASE BINDING 55 606 5.781e-16 3.836e-14
14 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 39 315 5.414e-16 3.836e-14
15 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 54 588 6.57e-16 4.069e-14
16 CYTOKINE RECEPTOR BINDING 36 271 7.998e-16 4.644e-14
17 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 80 1199 5.156e-15 2.818e-13
18 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 71 992 6.774e-15 3.496e-13
19 PROTEIN COMPLEX BINDING 68 935 1.247e-14 5.516e-13
20 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 38 328 1.148e-14 5.516e-13
21 CHROMATIN BINDING 44 435 1.237e-14 5.516e-13
22 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 20 90 1.264e-13 5.337e-12
23 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 30 226 2.196e-13 8.871e-12
24 PROTEIN HOMODIMERIZATION ACTIVITY 56 722 2.499e-13 9.674e-12
25 CORE PROMOTER BINDING 24 152 1.29e-12 4.795e-11
26 CYTOKINE ACTIVITY 28 219 3.56e-12 1.272e-10
27 GROWTH FACTOR RECEPTOR BINDING 20 129 1.375e-10 4.729e-09
28 PROTEIN HETERODIMERIZATION ACTIVITY 38 468 5.815e-10 1.929e-08
29 GLYCOPROTEIN BINDING 17 101 9.045e-10 2.897e-08
30 PROTEIN TYROSINE KINASE ACTIVITY 22 176 1.163e-09 3.601e-08
31 SIGNAL TRANSDUCER ACTIVITY 87 1731 1.413e-09 4.234e-08
32 HISTONE DEACETYLASE BINDING 17 105 1.685e-09 4.743e-08
33 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 19 133 1.658e-09 4.743e-08
34 PROTEIN SERINE THREONINE KINASE ACTIVITY 36 445 1.847e-09 5.046e-08
35 MOLECULAR FUNCTION REGULATOR 73 1353 1.909e-09 5.067e-08
36 GROWTH FACTOR BINDING 18 123 3.004e-09 7.752e-08
37 CELL ADHESION MOLECULE BINDING 22 186 3.329e-09 8.359e-08
38 GLYCOSAMINOGLYCAN BINDING 23 205 4.107e-09 1.004e-07
39 GROWTH FACTOR ACTIVITY 20 160 6.635e-09 1.58e-07
40 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 16 101 7.045e-09 1.636e-07
41 PROTEIN DOMAIN SPECIFIC BINDING 42 624 1.912e-08 4.332e-07
42 PEPTIDASE REGULATOR ACTIVITY 22 214 4.424e-08 9.786e-07
43 RECEPTOR ACTIVITY 79 1649 7.243e-08 1.565e-06
44 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 15 104 7.616e-08 1.608e-06
45 CYTOKINE BINDING 14 92 1.04e-07 2.148e-06
46 ENZYME REGULATOR ACTIVITY 53 959 1.845e-07 3.726e-06
47 ADENYL NUCLEOTIDE BINDING 73 1514 1.913e-07 3.781e-06
48 VIRUS RECEPTOR ACTIVITY 12 70 2.225e-07 4.219e-06
49 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 12 70 2.225e-07 4.219e-06
50 SMAD BINDING 12 72 3.065e-07 5.696e-06
51 PEPTIDASE ACTIVATOR ACTIVITY 9 38 4.152e-07 7.563e-06
52 PROTEASE BINDING 14 104 4.939e-07 8.788e-06
53 CORE PROMOTER PROXIMAL REGION DNA BINDING 28 371 5.014e-07 8.788e-06
54 INTEGRIN BINDING 14 105 5.566e-07 9.575e-06
55 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 13 92 7.164e-07 1.21e-05
56 RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 10 53 9.091e-07 1.508e-05
57 TRANSCRIPTION COACTIVATOR ACTIVITY 24 296 9.301e-07 1.516e-05
58 LOW DENSITY LIPOPROTEIN PARTICLE BINDING 6 15 1.217e-06 1.922e-05
59 G PROTEIN COUPLED RECEPTOR BINDING 22 259 1.221e-06 1.922e-05
60 HORMONE RECEPTOR BINDING 17 168 1.878e-06 2.908e-05
61 RECEPTOR SIGNALING PROTEIN ACTIVITY 17 172 2.599e-06 3.958e-05
62 HEPARIN BINDING 16 157 3.425e-06 5.132e-05
63 TRANSITION METAL ION BINDING 65 1400 3.483e-06 5.136e-05
64 RIBONUCLEOTIDE BINDING 80 1860 4.417e-06 6.411e-05
65 PLATELET DERIVED GROWTH FACTOR BINDING 5 11 4.686e-06 6.697e-05
66 PHOSPHATASE BINDING 16 162 5.15e-06 7.249e-05
67 TRANSCRIPTION COREPRESSOR ACTIVITY 19 221 5.427e-06 7.525e-05
68 SERINE HYDROLASE ACTIVITY 20 242 5.614e-06 7.559e-05
69 HISTONE ACETYLTRANSFERASE BINDING 7 28 5.612e-06 7.559e-05
70 SIGNALING RECEPTOR ACTIVITY 64 1393 5.858e-06 7.775e-05
71 CALCIUM ION BINDING 39 697 6.218e-06 8.136e-05
72 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 11 81 7.599e-06 9.805e-05
73 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 16 168 8.22e-06 0.0001046
74 SULFUR COMPOUND BINDING 19 234 1.233e-05 0.0001548
75 PROTEIN PHOSPHATASE BINDING 13 120 1.452e-05 0.0001761
76 CHEMOKINE RECEPTOR BINDING 9 57 1.479e-05 0.0001761
77 ACTIVATING TRANSCRIPTION FACTOR BINDING 9 57 1.479e-05 0.0001761
78 REPRESSING TRANSCRIPTION FACTOR BINDING 9 57 1.479e-05 0.0001761
79 LIPOPROTEIN PARTICLE RECEPTOR BINDING 6 22 1.554e-05 0.0001804
80 FERROUS IRON BINDING 6 22 1.554e-05 0.0001804
81 HEAT SHOCK PROTEIN BINDING 11 89 1.899e-05 0.0002152
82 CYTOKINE RECEPTOR ACTIVITY 11 89 1.899e-05 0.0002152
83 PROTEIN LIPID COMPLEX BINDING 6 24 2.682e-05 0.0003001
84 ICOSANOID RECEPTOR ACTIVITY 5 15 2.794e-05 0.000309
85 KINASE REGULATOR ACTIVITY 16 186 2.94e-05 0.0003186
86 CHEMOKINE ACTIVITY 8 48 2.949e-05 0.0003186
87 RETINOID X RECEPTOR BINDING 5 17 5.515e-05 0.0005889
88 BHLH TRANSCRIPTION FACTOR BINDING 6 28 6.873e-05 0.0007255
89 CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 7 42 9.339e-05 0.0009748
90 PHOSPHATIDYLINOSITOL 3 KINASE BINDING 6 30 0.0001037 0.00107
91 PROTEIN C TERMINUS BINDING 15 186 0.0001079 0.001102
92 RECEPTOR REGULATOR ACTIVITY 7 45 0.0001469 0.001483
93 ENHANCER BINDING 10 93 0.0001492 0.001484
94 RECEPTOR ACTIVATOR ACTIVITY 6 32 0.0001514 0.001484
95 ENZYME INHIBITOR ACTIVITY 23 378 0.0001517 0.001484
96 PEPTIDOGLYCAN BINDING 4 12 0.000188 0.001819
97 KINASE ACTIVATOR ACTIVITY 8 62 0.0001924 0.001842
98 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 7 47 0.0001947 0.001845
99 CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 6 34 0.000215 0.002018
100 SH3 DOMAIN BINDING 11 116 0.0002182 0.002028
101 PEPTIDASE INHIBITOR ACTIVITY 14 177 0.0002222 0.002044
102 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 64 0.0002407 0.002192
103 STEROID HORMONE RECEPTOR BINDING 9 81 0.0002474 0.002232
104 COLLAGEN BINDING 8 65 0.0002683 0.002329
105 CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 5 23 0.0002637 0.002329
106 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 4 13 0.000266 0.002329
107 RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC DNA BINDING 8 65 0.0002683 0.002329
108 STRUCTURAL CONSTITUENT OF CYTOSKELETON 10 100 0.000272 0.002339
109 AMIDE BINDING 18 272 0.0002852 0.002431
110 ENDOPEPTIDASE ACTIVITY 25 448 0.0003014 0.002546
111 EPHRIN RECEPTOR BINDING 5 24 0.000326 0.002728
112 LONG CHAIN FATTY ACID BINDING 4 14 0.0003648 0.003026
113 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 10 105 0.000404 0.003321
114 PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 6 39 0.0004674 0.003809
115 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II DISTAL ENHANCER SEQUENCE SPECIFIC BINDING 5 26 0.0004834 0.003905
116 ESTROGEN RECEPTOR BINDING 6 40 0.000538 0.004309
117 RNA POLYMERASE II TRANSCRIPTION COFACTOR ACTIVITY 9 91 0.0005917 0.004698
118 TRANSFORMING GROWTH FACTOR BETA BINDING 4 16 0.0006364 0.004846
119 RECEPTOR AGONIST ACTIVITY 4 16 0.0006364 0.004846
120 ENZYME ACTIVATOR ACTIVITY 25 471 0.0006282 0.004846
121 LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 4 16 0.0006364 0.004846
122 CXCR CHEMOKINE RECEPTOR BINDING 4 16 0.0006364 0.004846
123 METALLOENDOPEPTIDASE ACTIVITY 10 113 0.0007235 0.005465
124 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 8 76 0.0007819 0.005858
125 LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING 4 17 0.0008152 0.005963
126 NAD DEPENDENT PROTEIN DEACETYLASE ACTIVITY 4 17 0.0008152 0.005963
127 SIGNALING PATTERN RECOGNITION RECEPTOR ACTIVITY 4 17 0.0008152 0.005963
128 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 228 0.0009486 0.006819
129 HSP70 PROTEIN BINDING 5 30 0.0009615 0.006819
130 MHC PROTEIN BINDING 5 30 0.0009615 0.006819
131 TUMOR NECROSIS FACTOR RECEPTOR BINDING 5 30 0.0009615 0.006819
132 RETINOIC ACID RECEPTOR BINDING 6 45 0.001023 0.007203
133 LIPID BINDING 31 657 0.001064 0.007431
134 FATTY ACID BINDING 5 31 0.001122 0.00778
135 NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 6 46 0.001152 0.007924
136 CYCLIN BINDING 4 19 0.001274 0.008516
137 NITRIC OXIDE SYNTHASE BINDING 4 19 0.001274 0.008516
138 PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 4 19 0.001274 0.008516
139 HISTONE KINASE ACTIVITY 4 19 0.001274 0.008516
140 METALLOPEPTIDASE ACTIVITY 13 188 0.001298 0.008616
141 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 6 48 0.001444 0.009382
142 PROTEIN N TERMINUS BINDING 9 103 0.001442 0.009382
143 MONOCARBOXYLIC ACID BINDING 7 65 0.001443 0.009382
144 CYTOSKELETAL PROTEIN BINDING 36 819 0.00152 0.009807
145 UBIQUITIN LIKE PROTEIN LIGASE BINDING 16 264 0.001542 0.00982
146 ZINC ION BINDING 47 1155 0.001543 0.00982
147 MONOSACCHARIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 4 20 0.00156 0.009861
NumGOOverlapSizeP ValueAdj. P Value
1 CELL SURFACE 83 757 1.879e-29 1.097e-26
2 EXTRACELLULAR SPACE 108 1376 7.369e-26 2.152e-23
3 MEMBRANE MICRODOMAIN 42 288 8.292e-20 1.211e-17
4 SIDE OF MEMBRANE 51 428 7.423e-20 1.211e-17
5 EXTRACELLULAR MATRIX 47 426 4.956e-17 5.788e-15
6 INTRINSIC COMPONENT OF PLASMA MEMBRANE 102 1649 7.682e-17 6.831e-15
7 EXTERNAL SIDE OF PLASMA MEMBRANE 35 238 8.188e-17 6.831e-15
8 MEMBRANE REGION 75 1134 6.547e-14 4.779e-12
9 RECEPTOR COMPLEX 36 327 2.781e-13 1.805e-11
10 ANCHORING JUNCTION 43 489 3.016e-12 1.762e-10
11 CELL SUBSTRATE JUNCTION 38 398 5.003e-12 2.656e-10
12 PROTEINACEOUS EXTRACELLULAR MATRIX 35 356 1.566e-11 7.622e-10
13 PLASMA MEMBRANE RECEPTOR COMPLEX 24 175 2.842e-11 1.277e-09
14 PERINUCLEAR REGION OF CYTOPLASM 46 642 5.34e-10 2.228e-08
15 NUCLEAR CHROMOSOME 40 523 1.171e-09 4.275e-08
16 TRANSCRIPTION FACTOR COMPLEX 29 298 1.138e-09 4.275e-08
17 CHROMOSOME 55 880 1.57e-09 5.392e-08
18 INTRACELLULAR VESICLE 69 1259 2.973e-09 9.646e-08
19 VESICLE LUMEN 16 106 1.442e-08 4.431e-07
20 CELL JUNCTION 62 1151 3.886e-08 1.135e-06
21 CELL LEADING EDGE 29 350 4.278e-08 1.19e-06
22 CYTOPLASMIC VESICLE PART 40 601 5.717e-08 1.518e-06
23 ENDOCYTIC VESICLE 24 256 6.399e-08 1.625e-06
24 MEDIATOR COMPLEX 9 34 1.465e-07 3.565e-06
25 CHROMATIN 32 441 1.867e-07 4.362e-06
26 PLASMA MEMBRANE RAFT 13 86 3.218e-07 7.228e-06
27 PLASMA MEMBRANE REGION 51 929 3.909e-07 8.456e-06
28 VACUOLE 60 1180 4.731e-07 9.868e-06
29 PLASMA MEMBRANE PROTEIN COMPLEX 34 510 5.589e-07 1.126e-05
30 PROTEIN COMPLEX INVOLVED IN CELL ADHESION 8 30 6.895e-07 1.342e-05
31 ENDOSOME 45 793 8.044e-07 1.515e-05
32 ENDOPLASMIC RETICULUM LUMEN 19 201 1.331e-06 2.429e-05
33 CYTOPLASMIC SIDE OF MEMBRANE 17 170 2.212e-06 3.915e-05
34 NUCLEAR CHROMATIN 23 291 2.419e-06 4.154e-05
35 CELL PROJECTION 78 1786 3.379e-06 5.638e-05
36 TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 20 237 4.096e-06 6.644e-05
37 EXTRACELLULAR MATRIX COMPONENT 14 125 4.628e-06 7.305e-05
38 NUCLEAR TRANSCRIPTION FACTOR COMPLEX 14 127 5.582e-06 8.578e-05
39 BANDED COLLAGEN FIBRIL 5 12 7.862e-06 0.0001177
40 ENDOCYTIC VESICLE MEMBRANE 15 152 1.021e-05 0.0001462
41 EXTRINSIC COMPONENT OF MEMBRANE 20 252 1.026e-05 0.0001462
42 LAMELLIPODIUM 16 172 1.109e-05 0.0001541
43 RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX 12 101 1.204e-05 0.0001635
44 COLLAGEN TRIMER 11 88 1.704e-05 0.0002262
45 PLATELET ALPHA GRANULE 10 75 2.32e-05 0.000301
46 APICAL PART OF CELL 24 361 2.729e-05 0.0003464
47 ACTOMYOSIN 9 62 2.973e-05 0.0003694
48 VESICLE MEMBRANE 30 512 3.181e-05 0.000387
49 CELL BODY 29 494 4.157e-05 0.0004954
50 NUCLEOPLASM PART 37 708 4.69e-05 0.0005478
51 SECRETORY GRANULE 23 352 5.216e-05 0.0005973
52 EXTRINSIC COMPONENT OF PLASMA MEMBRANE 13 136 5.507e-05 0.0006185
53 GOLGI APPARATUS 62 1445 6.403e-05 0.0007056
54 ENDOPLASMIC RETICULUM 68 1631 6.647e-05 0.0007189
55 SECRETORY GRANULE LUMEN 10 85 6.949e-05 0.0007378
56 NEUROMUSCULAR JUNCTION 8 54 7.096e-05 0.00074
57 PHAGOCYTIC CUP 5 18 7.474e-05 0.0007658
58 PLATELET ALPHA GRANULE LUMEN 8 55 8.118e-05 0.0008173
59 SOMATODENDRITIC COMPARTMENT 34 650 9.338e-05 0.0009243
60 ACTIN FILAMENT BUNDLE 8 57 0.0001053 0.001025
61 SPINDLE MICROTUBULE 8 58 0.0001194 0.001143
62 NEURON PROJECTION 44 942 0.0001267 0.001174
63 EARLY ENDOSOME 20 301 0.0001265 0.001174
64 OUTER MEMBRANE 15 190 0.0001368 0.001248
65 MEMBRANE PROTEIN COMPLEX 46 1020 0.0001983 0.001781
66 NEURON PART 54 1265 0.0002217 0.001933
67 RUFFLE 13 156 0.0002217 0.001933
68 APICAL PLASMA MEMBRANE 19 292 0.000242 0.002078
69 DNA POLYMERASE COMPLEX 4 13 0.000266 0.002219
70 COMPLEX OF COLLAGEN TRIMERS 5 23 0.0002637 0.002219
71 TRANSFERASE COMPLEX 34 703 0.0004002 0.003292
72 CHROMOSOMAL REGION 20 330 0.0004226 0.003428
73 SECRETORY VESICLE 25 461 0.0004602 0.003681
74 ADA2 GCN5 ADA3 TRANSCRIPTION ACTIVATOR COMPLEX 4 15 0.0004872 0.003845
75 ER TO GOLGI TRANSPORT VESICLE 8 71 0.0004938 0.003845
76 PROTEIN KINASE COMPLEX 9 90 0.0005455 0.004137
77 CATALYTIC COMPLEX 45 1038 0.0005424 0.004137
78 ACTIN CYTOSKELETON 24 444 0.0006217 0.004655
79 AXON 23 418 0.0006297 0.004655
80 LYTIC VACUOLE 27 526 0.0006447 0.004706
81 TRANSCRIPTIONAL REPRESSOR COMPLEX 8 74 0.0006538 0.004714
82 BASEMENT MEMBRANE 9 93 0.0006938 0.004941
83 CYTOSKELETON 74 1967 0.0007086 0.004986
84 VACUOLAR LUMEN 10 115 0.0008296 0.005768
85 COATED VESICLE 15 234 0.001232 0.008462
86 SYNAPSE 34 754 0.001341 0.009103

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 TNF_signaling_pathway_hsa04668 31 108 4.95e-24 2.574e-22
2 PI3K_Akt_signaling_pathway_hsa04151 51 352 1.03e-23 2.679e-22
3 Cytokine_cytokine_receptor_interaction_hsa04060 41 270 5.033e-20 8.724e-19
4 FoxO_signaling_pathway_hsa04068 28 132 5.592e-18 7.27e-17
5 Apoptosis_hsa04210 28 138 1.942e-17 2.019e-16
6 MAPK_signaling_pathway_hsa04010 39 295 5.683e-17 4.925e-16
7 Focal_adhesion_hsa04510 30 199 6.935e-15 5.152e-14
8 Cellular_senescence_hsa04218 25 160 5.571e-13 3.621e-12
9 Cell_cycle_hsa04110 22 124 9.941e-13 5.744e-12
10 Rap1_signaling_pathway_hsa04015 26 206 2.854e-11 1.484e-10
11 Jak_STAT_signaling_pathway_hsa04630 23 162 3.6e-11 1.702e-10
12 Hippo_signaling_pathway_hsa04390 22 154 8.516e-11 3.69e-10
13 Phagosome_hsa04145 21 152 4.32e-10 1.728e-09
14 NF_kappa_B_signaling_pathway_hsa04064 16 95 2.806e-09 1.042e-08
15 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 19 139 3.528e-09 1.223e-08
16 Regulation_of_actin_cytoskeleton_hsa04810 22 208 2.644e-08 8.593e-08
17 TGF_beta_signaling_pathway_hsa04350 14 84 3.169e-08 9.692e-08
18 Ras_signaling_pathway_hsa04014 23 232 4.308e-08 1.217e-07
19 HIF_1_signaling_pathway_hsa04066 15 100 4.448e-08 1.217e-07
20 Adherens_junction_hsa04520 12 72 3.065e-07 7.97e-07
21 p53_signaling_pathway_hsa04115 11 68 1.302e-06 3.036e-06
22 ECM_receptor_interaction_hsa04512 12 82 1.307e-06 3.036e-06
23 Necroptosis_hsa04217 17 164 1.343e-06 3.036e-06
24 mTOR_signaling_pathway_hsa04150 14 151 4.036e-05 8.745e-05
25 Sphingolipid_signaling_pathway_hsa04071 12 118 5.786e-05 0.0001189
26 Apelin_signaling_pathway_hsa04371 13 137 5.943e-05 0.0001189
27 cAMP_signaling_pathway_hsa04024 16 198 6.269e-05 0.0001207
28 AMPK_signaling_pathway_hsa04152 12 121 7.399e-05 0.0001374
29 Calcium_signaling_pathway_hsa04020 15 182 8.449e-05 0.0001515
30 Gap_junction_hsa04540 10 88 9.352e-05 0.0001621
31 Autophagy_animal_hsa04140 12 128 0.0001274 0.0002137
32 Apoptosis_multiple_species_hsa04215 6 33 0.000181 0.0002941
33 ErbB_signaling_pathway_hsa04012 9 85 0.0003564 0.0005616
34 Oocyte_meiosis_hsa04114 11 124 0.0003901 0.0005966
35 VEGF_signaling_pathway_hsa04370 7 59 0.0008081 0.001201
36 cGMP_PKG_signaling_pathway_hsa04022 12 163 0.001153 0.001666
37 Cell_adhesion_molecules_.CAMs._hsa04514 11 145 0.001437 0.002019
38 Wnt_signaling_pathway_hsa04310 11 146 0.001518 0.002078
39 Phospholipase_D_signaling_pathway_hsa04072 10 146 0.00485 0.006467
40 Notch_signaling_pathway_hsa04330 5 48 0.007889 0.01026
41 Endocytosis_hsa04144 12 244 0.02608 0.03302
42 Mitophagy_animal_hsa04137 5 65 0.02667 0.03302
43 Neuroactive_ligand_receptor_interaction_hsa04080 13 278 0.0302 0.03652
44 Tight_junction_hsa04530 9 170 0.03364 0.03975
45 Hippo_signaling_pathway_multiple_species_hsa04392 3 29 0.03853 0.04452
46 Ferroptosis_hsa04216 3 40 0.08479 0.09586
47 Hedgehog_signaling_pathway_hsa04340 3 47 0.1223 0.1353
48 Lysosome_hsa04142 5 123 0.2156 0.2335
49 Peroxisome_hsa04146 3 83 0.3655 0.3879

Quest ID: bf93e6e98d689eb6c72d5f6f66085787